Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3012516	u-alb	mg/l (mg/l)	69534	194015	0.39%
3012516	u-alb	— (—)	68961	161709	100.00%	Distribution not available
3012516	u-albumiini	mg/l (mg/l)	2471	2890	0.00%
3012516	u-albumiini	— (—)	1616	1729	100.00%	Distribution not available
3012516	u-albumiinimikroalbuminuriamg/l(u-albkre)	mg/l (—)	763	1115	100.00%	Distribution not available
3012516	albumiini	g/l (mg/l)	736	2791	0.00%	Distribution not available
3012516	albumiini	mg/l (mg/l)	200	524	0.00%
3012516	albumiini	— (—)	151	495	100.00%	Distribution not available
3012516	album	g/l (mg/l)	112	346	0.00%	Distribution not available
3012516	u-alb-lb	mg/l (mg/l)	51	70	0.00%
3012516	u-alb-lb	— (—)	44	50	100.00%	Distribution not available
3012516	du-albumi	mg/l (mg/l)	33	50	0.00%
3012516	album	mg/l (mg/l)	31	113	0.00%
3012516	albumiini,virtsasta	mg/l (mg/l)	30	34	0.00%
3012516	albumiini,virtsasta	— (—)	9	9	100.00%	Distribution not available
3012516	album	— (—)	7	7	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma, unspecified (mode)

9833

51199

1.63

315.97

3.3

3.1

529.10

305.78

mg/l

3.90

6371

31769

Other antidepressants

18316

71008

1.44

314.81

3.3

458.66

403.90

mg/l

0.72

11832

46125

Symptoms and signs involving the urinary system

13843

77817

1.52

314.26

3.7

3.2

387.44

414.18

mg/l

0.29

9407

49211

Pre-eclampsia or poor fetal growth

4134

23158

2.07

312.11

4.0

3.1

387.78

494.66

mg/l

0.86

2871

13615

Elevated blood glucose level

1825

8012

3.66

311.73

4.3

3.2

241.36

310.18

mg/l

0.40

1330

5170

Hypothyroidism, strict autoimmune, 3 medication purchases required

14318

71314

1.49

309.72

3.5

3.2

389.21

422.23

mg/l

0.35

8789

45234

Dialysis

1074

3383

8.23

307.65

11.9

3.1

378.54

248.87

mg/l

0.88

1034

2193

Ischemic heart diseases

17081

64477

1.92

307.65

3.6

3.2

354.05

439.59

mg/l

1.61

11355

39570

Myocardial infarction

9342

45200

1.72

307.65

3.6

3.2

309.53

421.94

mg/l

1.99

6515

28190

Major coronary heart disease event

17335

66895

1.88

307.65

3.6

3.2

363.42

436.55

mg/l

1.26

11599

41149

Glomerular diseases

5022

19379

5.17

307.65

9.1

3.0

457.13

383.40

mg/l

0.92

4544

12582

Cardiac arrhythmias

9965

20265

3.99

307.65

3.4

2.1

434.14

1006.00

mg/l

12.45

6444

10628

Care involving dialysis

2314

8185

7.20

307.65

10.9

3.2

455.03

262.60

mg/l

2.71

2216

5286

Insulin, fast-acting or short human

14971

39184

14.20

307.65

5.6

3.0

127.57

450.41

mg/l

28.59

11779

24935

Obesity related asthma

6985

40252

2.24

307.65

3.4

3.3

345.33

388.80

mg/l

0.36

4725

25336

Insulin medication

24694

35122

18.63

307.65

5.1

2.2

131.03

888.86

mg/l

68.81

19160

19683

Vocal cord dysfunction

1897

5540

3.77

307.65

3.3

1.9

286.34

856.93

mg/l

4.19

1204

2766

Insulin, fast-acting

14919

35674

17.42

307.65

5.6

2.8

127.77

497.79

mg/l

30.78

11739

22207

Any reimbursement code in KELA

11165

15414

4.59

307.65

3.7

1.8

365.46

680.16

mg/l

5.11

7619

8034

Obesity

14794

67479

2.92

307.65

3.7

3.2

236.37

447.66

mg/l

10.13

10342

42260

Dyspnoea

17084

86617

1.67

307.65

3.5

3.2

451.81

412.12

mg/l

0.48

11183

55111

Type 1 diabetes, strict definition, subgroup 1

3321

1906

196.36

307.65

5.5

2.5

73.22

892.99

mg/l

5.48

2546

1170

General examination and investigation of persons without complaint and reported diagnosis

11436

39378

1.69

307.65

3.4

3.0

532.94

331.32

mg/l

3.77

8160

24962

Coronary revascularization (ANGIO or CABG)

16719

62991

2.00

307.65

3.6

3.2

371.49

444.40

mg/l

1.19

11219

38647

Hypertensive heart and/or renal disease

5699

18171

3.32

307.65

4.2

2.7

237.05

540.60

mg/l

7.41

4209

10389

Asthma, unspecified (mode), excluding more controls

9557

47731

1.71

307.65

3.3

3.1

536.04

300.38

mg/l

4.12

6203

29320

Insulin, fast-acting (human)

5506

10380

21.05

307.65

6.2

2.7

129.96

424.03

mg/l

7.40

4336

6466

Hypothyroidism (congenital or acquired)

4274

4464

6.82

307.65

3.8

1.9

491.75

775.02

mg/l

1.40

2834

2416

Diabetic maculopathy, excluding more controls

3784

5780

25.14

307.65

6.3

2.2

193.55

825.60

mg/l

9.28

3021

3221

Insulin, intermediate and long-acting

23325

59903

14.69

307.65

5.1

2.8

123.76

491.49

mg/l

50.57

18145

37117

Transplanted organ and tissue status

2499

9281

5.30

307.65

10.0

3.1

544.76

334.96

mg/l

1.53

2202

6034

Other soft tissue disorders, not elsewhere classified

16697

67381

1.62

307.65

3.5

3.2

629.76

359.46

mg/l

7.33

11015

43199

Special screening examination for other diseases and disorders

3203

10161

5.96

307.65

4.2

3.0

89.37

322.42

mg/l

5.91

2552

6466

Hypothyroidism and >3 levothyroxin purchases

4219

4458

6.73

307.65

3.8

1.9

499.84

775.65

mg/l

1.33

2786

2414

Hypertensive diseases

20032

40446

4.02

307.65

3.9

2.7

302.45

578.92

mg/l

10.79

13937

23232

Persons encountering health services for specific procedures and health care

19862

82923

1.61

307.65

4.0

3.1

589.96

360.29

mg/l

7.41

13754

52005

Presence of other functional implants

11369

55262

1.66

307.65

3.8

3.1

306.56

402.23

mg/l

1.62

7072

34455

ILD medications

20039

81042

1.46

307.65

4.1

3.1

646.39

322.71

mg/l

12.75

13627

51354

Persons encountering health services for examination and investigation

11413

39417

1.60

307.65

3.5

3.0

429.08

331.08

mg/l

1.30

7561

24986

Other special examinations and investigations of persons without complaint or reported diagnosis

12645

39417

1.86

307.65

3.7

3.0

523.21

331.08

mg/l

3.58

8504

24986

Presence of cardiac and vascular implants and grafts

8870

44300

1.79

307.65

3.5

3.1

391.41

384.30

mg/l

0.05

6295

28692

Antihypertensive medication - note that there are other indications

11242

15669

4.82

307.65

3.7

2.8

345.04

825.94

mg/l

10.94

7698

9181

Medical observation and evaluation for suspected diseases and conditions

12060

39414

1.77

307.65

3.8

3.0

348.12

331.08

mg/l

0.15

7657

24986

Sleep apnoea, including avohilmo

21689

77945

2.13

307.65

3.4

3.2

330.31

449.99

mg/l

3.38

14179

49232

Examination and observation for other reasons

10028

39187

1.65

307.65

3.5

3.0

338.51

327.62

mg/l

0.09

6801

24826

Preparatory care for dialysis

1261

4285

9.88

307.65

12.1

3.3

319.66

328.76

mg/l

0.05

1225

2816

Hypertension

20031

40435

4.03

307.65

3.9

2.7

302.53

579.11

mg/l

10.79

13935

23224

Type 2 diabetes, strict (exclude DM1)

38039

39202

14.06

307.65

3.5

2.1

157.41

965.63

mg/l

73.25

25726

21089

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

44194

39216

23.65

307.65

4.1

2.1

130.81

965.79

mg/l

81.10

31182

21098

Anaemias

4192

4288

8.65

307.65

4.9

1.9

908.47

787.53

mg/l

0.36

3079

2295

Other retinal disorders

14866

65589

2.33

307.65

4.6

3.1

338.56

412.96

mg/l

1.37

10302

41462

Hard cardiovascular diseases

16877

63453

1.90

307.65

3.6

3.2

389.03

428.87

mg/l

0.50

11258

38828

Chronic periodontitis, including avohilmo

18287

86755

1.61

307.65

3.7

3.2

344.38

433.17

mg/l

1.90

11978

55109

Depression medications

4064

4616

5.23

307.65

3.4

1.9

407.11

763.50

mg/l

2.17

2691

2521

Extracorporeal dialysis

1517

5970

5.37

307.65

10.2

3.3

549.35

273.96

mg/l

2.93

1439

3973

All-cause Heart Failure

11314

56652

1.66

307.65

3.9

3.2

401.42

402.51

mg/l

0.01

8334

35492

Disorders of lens

13726

55868

1.84

307.65

4.0

3.1

361.64

423.08

mg/l

0.88

9264

35105

Infections, IBD-co-morbidities

2566

4749

4.96

307.65

4.7

1.8

1009.30

478.10

mg/l

2.98

1840

2478

Renal tubulo-interstitial diseases

19573

80135

2.31

307.65

4.9

2.9

393.60

420.84

mg/l

0.40

14836

48906

Hypertension, essential

19431

39916

3.96

307.65

3.7

2.7

314.52

583.12

mg/l

9.74

13436

22864

Heart failure and antihypertensive medication

5377

7715

7.05

307.65

4.3

2.6

306.58

1058.55

mg/l

10.83

4015

3990

Ischaemic heart disease, wide definition

16090

64218

1.89

307.65

3.6

3.2

352.80

442.46

mg/l

1.68

10740

39624

Disorders of gallbladder, biliary tract and pancreas

18734

83182

1.61

307.65

3.5

3.2

396.21

421.35

mg/l

0.30

12361

52672

Insulin, combination of fast acting with intermediate-acting or long-acting

24709

63542

10.04

307.65

5.1

2.8

130.98

491.56

mg/l

50.34

19169

39283

Pure hypercholesterolaemia

18157

62311

2.57

307.65

3.7

3.0

322.28

413.30

mg/l

1.99

12316

38418

ILD medications: prednisolone, methylprednisolone, prednisone

19633

80615

1.50

307.65

4.0

3.1

590.60

320.02

mg/l

9.68

13327

51025

Type 2 diabetes

40794

39633

15.55

307.65

3.8

2.1

153.14

966.29

mg/l

76.32

28114

21366

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1820

3690

4.67

307.65

3.7

1.8

765.66

391.80

mg/l

1.50

1212

1898

Atrial fibrillation and flutter

5966

17133

2.89

307.65

3.6

2.7

403.43

523.52

mg/l

0.96

4078

9541

Acute renal failure

4830

24701

2.85

307.65

5.2

2.9

443.26

366.57

mg/l

0.68

3917

15570

Major coronary heart disease event excluding revascularizations

11681

53773

1.70

307.65

3.5

3.2

365.65

425.60

mg/l

0.76

8034

33344

Percutaneous Coronary Intervention

16781

62970

2.01

307.65

3.6

3.2

376.66

444.55

mg/l

1.06

11251

38634

Disorders of lipoprotein metabolism and other lipidaemias

20653

65200

2.66

307.65

3.8

3.0

323.09

407.41

mg/l

1.92

14054

40221

Emergency coronary revascularization (for ACS)

18084

68592

1.95

307.65

3.5

3.2

373.51

435.75

mg/l

1.01

12130

42306

Atrial fibrillation and flutter with reimbursement

5417

14230

3.33

307.65

3.5

2.7

284.29

497.91

mg/l

2.59

3688

7813

Heart failure, not strict

17842

66135

2.48

307.65

4.6

3.0

387.48

409.66

mg/l

0.28

13145

39968

Diabetes mellitus

43677

40451

16.74

307.65

4.0

2.2

148.95

956.47

mg/l

78.66

30355

21951

Chronic apical periodontitis

20202

84655

1.50

307.65

3.5

3.2

389.07

422.35

mg/l

0.44

13217

54120

Cardiovascular diseases

9829

23850

2.59

307.65

3.8

2.9

394.28

469.77

mg/l

0.73

6683

14505

Renal failure

12523

50534

3.57

307.65

6.0

3.0

388.46

409.21

mg/l

0.25

10365

31631

Other disorders of glucose regulation and pancreatic internal secretion

1924

7555

4.23

307.65

5.3

3.3

190.20

294.10

mg/l

0.86

1467

4946

Glomerular disorders in diseases classified elsewhere

3550

11987

8.02

307.65

9.4

3.1

431.42

312.09

mg/l

1.68

3266

7800

Diabetes, insulin treatment (Kela reimbursement)

46409

48185

19.53

307.65

4.1

2.3

134.56

830.05

mg/l

81.26

32777

26655

Coronary atherosclerosis

13754

54540

1.98

307.65

3.6

3.2

308.00

432.92

mg/l

2.88

9387

33562

Polyarthropathies

12934

53462

1.84

307.65

4.0

3.2

577.64

357.34

mg/l

4.91

9119

34140

Type 1 diabetes, definitions combined

3951

3149

69.87

307.65

5.5

2.3

81.42

721.79

mg/l

6.46

3005

1847

Gout, strict definition

4053

22040

2.76

307.65

4.7

3.2

324.26

355.84

mg/l

0.23

3154

14710

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

6665

22154

2.19

307.65

3.6

2.7

551.24

513.67

mg/l

0.20

4274

12604

Hypertensive Heart Disease

4867

17053

3.07

307.65

3.8

2.7

220.69

541.62

mg/l

7.26

3480

9745

Type 1 diabetes, strict definition

3431

2067

152.36

307.65

5.5

2.5

72.41

868.39

mg/l

5.66

2632

1261

Heart failure,strict

10740

49220

1.90

307.65

4.0

3.0

393.17

396.61

mg/l

0.03

7929

30036

Autoimmune diseases excluding thyroid diseases, strict definition

21245

67857

2.04

307.65

4.3

2.9

434.24

395.52

mg/l

0.54

15198

42767

Chronic kidney disease

9138

34818

5.08

307.65

6.9

2.9

350.35

387.99

mg/l

0.52

7842

22003

Shoulder lesions

14503

62212

1.60

307.65

3.4

3.2

386.43

357.63

mg/l

0.30

9595

39348

Disorders of thyroid, IBD co-morbidities

2785

5194

4.69

307.65

3.7

1.8

453.39

469.85

mg/l

0.05

1802

2771

Diseases of the eye and adnexa

13419

46776

1.57

307.65

3.8

3.0

412.75

390.70

mg/l

0.20

9087

30110

Thiazolidinediones

3656

7938

17.03

307.65

4.7

2.4

149.38

642.82

mg/l

9.29

2837

4511

Other nutritional deficiencies

15233

69999

2.77

307.65

3.7

3.2

253.59

443.97

mg/l

8.15

10629

43888

Sub-endpoint used in defining T1D endpoints

10659

27665

9.47

307.65

5.8

3.0

133.27

425.94

mg/l

17.96

8310

17901

Type 1 diabetes, wide definition, subgroup 1

9083

9891

54.69

307.65

6.0

2.2

121.19

900.62

mg/l

21.41

7112

5577

Episodal and paroxysmal disorders

19872

69898

1.61

307.65

3.3

408.64

413.55

mg/l

0.05

13115

44426

Sulfonylureas

9434

22210

6.14

307.65

4.8

2.4

139.68

760.28

mg/l

34.70

7128

12785

Cholelithiasis

15133

76378

1.52

307.65

3.4

3.2

409.62

425.33

mg/l

0.15

9740

47887

Diseases of arteries, arterioles and capillaries (FINNGEN)

5055

13952

3.47

307.65

4.2

2.7

351.49

494.64

mg/l

1.33

3693

7796

Type 1 diabetes

10307

12809

31.83

307.65

5.9

2.2

129.88

894.52

mg/l

26.25

8046

7264

Other heart diseases, wide

16238

68182

1.63

307.65

3.6

3.2

463.76

390.20

mg/l

1.07

10730

42709

Type 1 diabetes, strict (exclude DM2)

3940

3131

72.35

307.65

5.5

2.3

81.62

721.96

mg/l

6.46

2996

1847

Hypertensive diseases (excluding secondary)

13575

23513

5.06

307.65

4.0

2.7

317.15

508.34

mg/l

3.74

9565

13471

Glomerulonephritis

2200

9720

3.67

307.65

9.1

3.2

543.44

289.08

mg/l

3.10

1964

6355

Secondary hypertension

2234

5292

9.08

307.65

9.2

2.7

309.57

535.16

mg/l

1.71

1923

3038

Statin medication

17111

25853

5.42

307.65

3.9

2.4

238.45

849.97

mg/l

29.09

11752

14794

Chronic periodontitis, complicated

10344

71573

1.69

307.65

3.9

3.2

234.52

438.96

mg/l

7.69

6925

45479

STROKE

10075

40823

2.00

307.65

3.4

2.8

504.24

519.89

mg/l

0.10

6682

23597

Periodontitis

18346

86740

1.61

307.65

3.7

3.2

350.81

432.61

mg/l

1.65

12007

55105

Senile cataract

12482

51487

1.77

307.65

3.9

3.1

341.36

411.65

mg/l

1.04

8282

32256

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

19015

78865

1.83

307.65

4.2

3.1

411.78

408.66

mg/l

0.03

12779

49886

Hypothyroidism, strict autoimmune

12909

58167

1.64

307.65

3.6

2.9

387.85

405.93

mg/l

0.16

8022

36104

Biguanides

40787

47504

14.80

307.65

3.7

2.6

137.06

808.49

mg/l

77.57

28033

27073

Implicit Sepsis

14560

75291

1.69

307.65

4.0

3.1

463.00

383.84

mg/l

1.25

10394

46925

Obesity due to excess calories

11228

49623

3.28

307.65

3.7

3.3

235.90

447.92

mg/l

7.94

7803

31189

Cholelithiasis, broad definition with cholecystitis

15741

77676

1.52

307.65

3.4

3.2

417.50

424.15

mg/l

0.06

10186

48776

Carpal tunnel syndrome

11419

67956

1.73

307.65

3.6

3.1

445.83

399.49

mg/l

0.44

7446

42066

Finngen Rheumatological endpoints

16828

68834

1.53

307.65

3.5

3.2

503.91

354.64

mg/l

3.20

11205

43967

Hypothyroidism, levothyroxine purchases

4219

4458

6.73

307.65

3.8

1.9

499.84

775.65

mg/l

1.33

2786

2414

Diseases of oesophagus, stomach and duodenum

19249

84001

1.52

307.65

3.5

3.2

554.03

375.95

mg/l

4.38

12478

53757

Condition for Implicit Sepsis (Organ dysfunction codes)

16351

79197

1.67

307.65

3.9

3.1

437.12

390.62

mg/l

0.63

11386

49365

Pain in throat and chest

15790

61765

1.74

307.65

3.3

3.2

406.51

387.49

mg/l

0.18

10194

39417

Condition for Implicit Sepsis (Organ dysfunction codes)

17024

79392

1.69

307.65

3.9

3.1

438.54

388.86

mg/l

0.70

11847

49438

Obesity, other/unspecified

7044

32608

2.92

307.65

3.6

3.2

198.26

478.07

mg/l

9.44

4990

20355

Symptoms and signs involving the circulatory and respiratory systems

17142

62700

1.49

307.65

3.4

3.2

439.93

389.08

mg/l

0.66

11251

40133

Complications of surgical and medical care, not elsewhere classified

17782

89778

1.50

307.65

3.6

3.2

539.22

390.82

mg/l

3.26

11958

56886

Sleep apnoea

21074

77629

2.22

307.65

3.5

3.2

320.71

447.41

mg/l

3.78

13943

48811

Erysipelas

14677

73922

1.79

307.65

3.8

3.1

406.01

366.47

mg/l

0.50

10337

45850

Diabetes, varying definitions

43340

40742

16.44

307.65

4.0

2.2

148.44

945.33

mg/l

78.12

30099

22173

Cerebrovascular diseases (FINNGEN)

5600

17895

2.78

307.65

3.5

2.7

501.55

532.48

mg/l

0.15

3814

9999

Continuous positive airway pressure

3916

8240

5.95

307.65

4.0

2.0

119.78

768.55

mg/l

12.80

2648

4310

Abnormalities of breathing

17053

62579

1.81

307.65

3.5

3.2

486.42

389.69

mg/l

1.57

11290

40050

Gonarthrosis [arthrosis of knee](FG)

14179

60255

1.53

307.65

3.2

3.1

356.00

360.20

mg/l

0.04

9108

37771

All kidney diseases

22262

81371

2.36

307.65

4.8

2.9

412.49

411.98

mg/l

0.01

16809

49150

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

1370

2691

33.54

307.65

6.8

2.9

184.38

452.11

mg/l

1.64

1077

1701

Sleep disorders (combined)

21492

76263

1.68

307.65

3.4

3.3

389.88

430.81

mg/l

0.59

14151

48405

Tramadol

16075

61048

1.91

307.65

3.6

3.2

382.14

370.16

mg/l

0.12

10837

38224

Hypothyroidism, drug reimbursement

2413

3201

7.05

307.65

4.0

1.7

574.04

715.54

mg/l

0.36

1515

1595

Gout, unspecified

4369

25153

2.44

307.65

4.6

3.2

327.07

339.82

mg/l

0.08

3342

16685

Glucagon-like peptide-1 (GLP-1) analogues

11548

19938

31.14

307.65

4.4

2.6

85.51

845.86

mg/l

42.04

8807

11308

Implicit Sepsis

15795

78683

1.69

307.65

4.0

3.1

461.74

385.68

mg/l

1.22

11136

49011

Parasetamol

13523

42348

1.82

307.65

3.5

3.1

443.02

349.79

mg/l

1.34

9125

26950

Other bacterial diseases

18490

83602

1.72

307.65

4.0

3.1

555.99

371.52

mg/l

5.25

13160

52076

Diabetes medication

45783

43895

17.72

307.65

4.0

2.2

140.56

914.87

mg/l

83.30

31927

24129

Opioids

17313

63803

1.55

307.65

3.5

3.2

461.72

369.14

mg/l

1.57

11486

40296

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

18918

87344

1.72

307.65

4.1

3.1

718.85

339.96

mg/l

15.58

13282

54692

Kidney transplant status

1670

4450

15.91

307.65

12.7

3.1

200.28

257.00

mg/l

0.43

1604

2907

Nerve, nerve root and plexus disorders

21265

85434

1.77

307.65

3.7

3.2

500.28

388.89

mg/l

2.31

14158

54261

Type1 diabetes, definitions combined, early onset

2639

2875

64.52

307.65

5.6

3.4

106.69

402.84

mg/l

2.93

2046

1988

Gestational diabetes (for exclusion)

4572

16285

2.24

307.65

3.4

3.3

217.09

549.52

mg/l

6.57

3123

9945

Type 1 diabetes, wide definition

9271

10706

40.55

307.65

5.9

2.2

124.85

888.78

mg/l

22.43

7258

6068

Spondylopathies

14993

63366

1.60

307.65

3.3

601.96

319.26

mg/l

7.57

9746

40305

Type 2 diabetes, definitions combined

37906

38904

14.12

307.65

3.5

2.1

155.93

972.40

mg/l

73.68

25645

20892

Type 2 diabetes, wide definition

31750

38072

14.88

307.65

4.2

2.3

187.45

887.90

mg/l

57.72

22790

20758

Pregnancy hypertension

6493

31579

2.21

307.65

3.7

3.1

294.71

496.63

mg/l

3.81

4487

18002

All chronic kidney diseases

15425

53611

3.79

307.65

6.0

2.9

359.72

411.10

mg/l

0.95

12831

32439

Pre-eclampsia or eclampsia

3573

17171

2.67

307.65

4.1

3.1

365.86

533.82

mg/l

1.56

2521

9760

Type 2 diabetes, definitions combined, including avohilmo

37197

37828

13.53

307.65

3.5

2.1

161.15

987.30

mg/l

72.38

25019

20386

Oral corticosteroids

18842

84307

1.45

307.65

3.5

3.2

677.50

344.37

mg/l

11.84

12515

53550

Autoimmune diseases excluding thyroid diseases

21802

69640

2.03

307.65

4.3

2.9

457.93

400.00

mg/l

0.93

15561

43854

Codeine

17839

63468

1.74

307.65

3.4

3.2

414.98

370.19

mg/l

0.58

11810

40043

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

11548

19938

31.14

307.65

4.4

2.6

85.51

845.86

mg/l

42.04

8807

11308

Pre-eclampsia

3291

15392

2.75

307.65

4.2

3.1

390.70

535.33

mg/l

1.12

2345

8790

Codeine or tramadol medication

21859

80999

1.68

307.65

3.4

3.3

411.59

416.05

mg/l

0.04

14468

51573

Angina pectoris

11763

50471

1.91

307.65

3.5

3.2

424.74

429.59

mg/l

0.04

7948

31039

Used for control exclusion in common control thyroid runs

21012

65413

1.88

307.65

4.1

2.9

421.72

396.28

mg/l

0.31

14531

41262

Gestational [pregnancy-induced] hypertension

3465

18070

2.26

307.65

3.3

3.2

279.96

548.30

mg/l

3.47

2404

10476

Gout, FINNGEN

6295

37303

2.25

307.65

4.6

3.2

511.40

335.90

mg/l

2.38

4766

24567

Erysipelas

10873

66517

1.69

307.65

3.8

3.1

398.45

356.67

mg/l

0.47

7731

41776

Diabetes mellitus in pregnancy

4681

11832

3.08

307.65

4.1

3.0

239.51

573.54

mg/l

5.40

3316

7097

Combinations of oral blood glucose lowering drugs

10616

21449

22.24

307.65

4.2

2.5

116.02

799.65

mg/l

37.21

7967

12418

Heart failure, strict

11505

57398

1.67

307.65

3.9

3.2

396.81

402.33

mg/l

0.05

8489

35974

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

7211

35654

2.09

307.65

3.7

3.1

292.67

505.51

mg/l

4.55

4973

20074

Non-invasive ventilation

4762

10278

5.91

307.65

3.5

2.0

2476.05

768.43

mg/l

18.35

3052

5376

Unspecified kidney failure

2305

10286

3.60

307.65

5.7

2.9

377.91

308.60

mg/l

0.47

1948

6487

Other cataract

8475

42268

1.81

307.65

4.0

3.1

330.48

419.71

mg/l

1.18

5650

26455

Neurological diseases, wide definition

4458

6084

4.35

307.65

3.5

1.9

474.99

447.10

mg/l

0.11

3045

3336

Influenza and pneumonia

18101

87052

1.44

307.65

3.8

3.2

645.41

351.20

mg/l

10.08

12531

54727

Hyperlipidaemia, other/unspecified

8447

45446

2.25

307.65

3.9

3.1

376.53

383.71

mg/l

0.05

5734

28344

Dialysis, with operation codes

3324

13097

5.01

307.65

9.4

3.0

429.01

356.54

mg/l

0.67

3057

8378

Gout, idiopatic and unspecified

5376

31261

2.39

307.65

4.5

3.2

321.35

352.58

mg/l

0.27

4088

20765

Other blood glucose lowering drugs, excl. Insulins

4933

11458

11.49

307.65

4.8

2.4

143.04

707.26

mg/l

14.95

3768

6395

Other (not insulin) diabetes medications

40878

42546

15.43

307.65

3.7

2.2

146.88

927.30

mg/l

78.99

28028

23214

Other bacterial diseases

19825

82582

1.76

307.65

4.0

3.1

557.91

368.53

mg/l

5.63

14014

51234

Dipeptidyl peptidase 4 (DPP-4) inhibitors

22376

36129

19.71

307.65

4.4

2.5

147.33

841.56

mg/l

59.46

16419

20292

Nephropathy related operations

3109

12826

4.67

307.65

9.3

3.2

459.31

346.36

mg/l

1.19

2849

8418

L04AD Calcineurin inhibitors

2606

10058

4.72

307.65

10.1

3.1

328.56

340.60

mg/l

0.06

2290

6484

Pain in limb

14653

66294

1.67

307.65

3.5

3.2

627.63

357.94

mg/l

6.63

9671

42392

Autoimmune diseases

22552

69874

1.91

307.65

4.1

2.9

414.22

401.83

mg/l

0.14

15659

43991

Metabolic disorders

22351

70182

2.52

307.65

3.9

3.0

393.43

409.34

mg/l

0.19

15247

43503

Cardiovascular diseases (excluding rheumatic etc)

11787

27140

3.08

307.65

3.8

2.8

388.41

484.50

mg/l

1.16

8053

16154

Spinal stenosis

9987

52912

1.68

307.65

3.4

3.2

593.70

315.79

mg/l

5.24

6492

33299

Endocrine, nutritional and metabolic diseases

20051

22764

6.33

307.65

3.8

2.0

278.09

937.82

mg/l

27.15

13908

12368

Neurological diseases

14670

50821

1.59

307.65

3.4

3.2

487.04

333.62

mg/l

2.97

9764

32170

Acute tubulo-interstitial nephritis

10924

65074

1.64

307.65

4.1

3.0

403.21

429.35

mg/l

0.25

7825

39483

Other heart diseases

8293

23550

2.81

307.65

3.8

2.8

490.07

501.45

mg/l

0.06

5652

13653

Obesity and other hyperalimentation

14843

67763

2.91

307.65

3.7

3.2

235.85

447.72

mg/l

10.24

10373

42442

Other intervertebral disc disorders

15038

66028

1.52

307.65

3.2

3.3

627.90

322.84

mg/l

8.05

9718

42211

Gout

6295

30079

2.54

307.65

4.6

3.2

511.40

332.27

mg/l

2.41

4766

19641

Disorders of choroid and retina

17814

77079

2.04

307.65

4.3

3.1

359.35

418.61

mg/l

1.03

12141

48618

Heart failure and coronary heart disease

7996

38302

1.77

307.49

3.9

3.2

359.60

419.64

mg/l

0.68

5976

24037

Persons encountering health services in other circumstances, wide

20641

82042

1.40

307.42

3.6

3.2

270.30

464.54

mg/l

9.82

14558

51135

Other disorders of skin and subcutaneous tissue

12396

80471

1.54

307.10

4.1

3.2

425.40

425.91

mg/l

0.00

8522

50396

IgA nephropathy (IgA glomerulonephritis)

731

2026

15.16

306.35

9.9

3.3

366.12

271.51

mg/l

0.37

693

1362

Inflammatory bowel disease treatment related agents

19825

85348

1.41

306.27

3.6

3.2

640.18

345.06

mg/l

10.49

13322

54351

Paroxysmal tachycardia

3291

14336

2.26

304.75

3.3

2.7

317.46

525.37

mg/l

1.71

2122

8083

Persons encountering health services for other counselling and medical advice, not elsewhere classified

19570

81827

1.41

303.88

3.6

3.2

231.65

465.57

mg/l

15.27

14131

51003

Diseases of pulp and periapical tissues, including avohilmo

18256

71888

1.43

303.06

3.4

3.2

389.78

432.10

mg/l

0.56

11944

45852

Gonarthrosis,primary

16543

77553

1.46

300.16

3.2

378.97

420.10

mg/l

0.51

10509

49209

Other diseases of intestines

17892

77371

1.42

299.95

3.4

3.3

546.55

366.03

mg/l

4.22

11636

49745

Hypertensive Renal Disease

859

2505

6.46

298.98

6.3

2.7

250.99

347.79

mg/l

0.53

742

1485

Soft tissue disorders

17439

67790

1.43

298.92

3.4

3.2

473.26

358.79

mg/l

2.16

11531

43498

All pneumoniae

17293

88107

1.43

297.73

3.8

3.2

649.16

354.45

mg/l

9.79

12002

55416

Dorsalgia

16957

68538

1.44

296.23

3.3

538.62

322.45

mg/l

5.63

11080

44164

Other CVD (FINNGEN)

2042

7032

2.99

295.60

3.9

2.7

484.24

471.60

mg/l

0.04

1392

3888

Symptoms and signs involving cognition, perception, emotional state and behaviour

16855

87503

1.43

295.36

3.3

535.34

393.66

mg/l

2.72

10822

56045

Disorders resulting from impaired renal tubular function

984

3382

8.00

294.70

9.9

3.2

263.53

243.48

mg/l

0.11

907

2199

Viral hepatitis, IBD co-morbidity

680

1542

5.53

292.58

3.4

1.8

305.56

704.14

mg/l

1.04

444

838

L04AA Selective immunosuppressants

3989

23213

2.16

292.07

7.6

3.1

339.92

449.96

mg/l

1.07

3205

14571

Pneumonias (Asthma/COPD co-morbidities)

17167

88062

1.42

291.09

3.8

3.2

641.29

355.58

mg/l

9.30

11935

55344

Diverticular disease of intestine

13577

64401

1.51

290.42

3.4

3.2

485.73

369.46

mg/l

1.81

8831

40492

Bleeding

14965

80368

1.47

289.09

3.8

3.2

442.37

411.74

mg/l

0.34

10312

50720

Gonarthrosis

11944

49280

1.54

285.64

3.2

3.1

366.55

359.17

mg/l

0.06

7737

31115

Lower back pain or/and sciatica

18158

91517

1.41

285.47

3.3

573.99

382.77

mg/l

4.52

11716

58686

Nonalcoholic fatty liver disease

1979

9278

3.19

285.33

3.6

3.3

234.45

406.76

mg/l

1.22

1408

5868

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

1222

4373

3.84

283.46

3.9

3.0

117.34

524.16

mg/l

4.10

857

2563

Hypoglycaemia, other or unspecified

1447

5903

3.88

282.56

5.2

3.3

192.13

323.59

mg/l

0.97

1101

3883

Asthma, excluding more controls

13150

50123

1.50

282.48

3.3

3.1

560.08

300.23

mg/l

6.00

8624

31039

Implicit bacterial Sepsis

8472

51033

1.68

281.69

4.3

3.1

546.68

375.07

mg/l

2.66

6332

32129

Other disorders of fluid, electrolyte and acid-base balance

5628

34339

1.88

280.76

4.1

3.1

552.42

399.37

mg/l

1.50

3942

21168

Other disorders involving the immune mechanism, not elsewhere classified

829

2591

8.15

279.69

9.3

3.3

568.66

267.61

mg/l

1.28

768

1743

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

790

2412

8.87

277.86

9.5

3.3

587.18

283.47

mg/l

1.21

737

1627

Ulcer of lower limb, not elsewhere classified

2971

16417

2.55

277.64

5.0

3.1

234.51

326.19

mg/l

1.25

2340

10560

Myocardial infarction, strict

8602

42823

1.68

276.47

3.6

3.2

321.32

416.57

mg/l

1.41

5996

26821

Hypothyreosis and Thyroxine purchase for inclusion criteria

15594

77707

1.44

275.50

3.5

3.2

432.13

423.80

mg/l

0.07

9662

49685

Hypothyroidism, other/unspecified

15090

75050

1.44

274.90

3.5

3.2

426.79

420.51

mg/l

0.05

9373

48052

15467

71024

1.44

271.16

3.8

3.2

654.25

348.76

mg/l

9.24

10714

44202

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

15467

71024

1.44

271.16

3.8

3.2

654.25

348.76

mg/l

9.24

10714

44202

Diseases of arteries, arterioles and capillaries

12336

67900

1.52

270.38

4.0

3.2

393.46

407.82

mg/l

0.14

8937

42805

Low back pain

12717

67551

1.48

269.13

3.3

645.80

320.88

mg/l

7.81

8172

43414

Bacterial Sepsis

8707

52533

1.64

268.47

4.4

3.1

592.46

370.41

mg/l

3.99

6519

33127

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

16790

88263

1.41

268.27

3.8

3.2

632.07

357.07

mg/l

8.64

11679

55507

Genitourinary diseases

10041

35287

1.56

266.20

3.9

2.9

393.29

367.39

mg/l

0.22

7091

22472

Caries of dentine, including avohilmo

14030

53517

1.46

264.19

3.4

3.1

406.09

421.29

mg/l

0.13

9142

33868

Gingivitis and periodontal diseases

17978

71828

1.40

263.67

3.5

3.2

363.83

422.18

mg/l

0.91

11661

45902

Intracranial trauma

8981

43912

1.57

262.58

3.3

3.2

428.78

336.38

mg/l

1.02

5869

27605

Other dialysis

831

2777

8.64

261.29

12.5

3.3

326.46

224.99

mg/l

0.77

800

1859

Disorder of lipoprotein metabolism, unspecified

2716

14792

2.54

260.86

4.2

3.1

275.39

347.64

mg/l

0.48

1977

9311

Complications of procedures, not elsewhere classified

13953

87759

1.44

257.65

3.5

3.2

526.40

387.30

mg/l

2.49

9450

55454

Diseases of the skin and subcutaneous tissue

17458

67549

1.39

256.92

3.6

3.1

493.95

372.67

mg/l

2.32

11568

42868

Dental caries, including avohilmo

13274

50528

1.47

256.24

3.4

3.1

387.98

425.70

mg/l

0.40

8686

31911

Infections of the skin and subcutaneous tissue

9583

68283

1.55

255.96

4.0

3.3

441.90

396.40

mg/l

0.44

6794

44389

Charcot foot

524

1255

15.19

255.84

7.3

2.8

273.54

236.59

mg/l

0.11

448

756

Rotator cuff syndrome

11210

59290

1.52

255.14

3.3

3.2

403.50

355.15

mg/l

0.50

7338

37401

Dental operations

11275

42029

1.52

255.00

3.3

3.1

378.84

344.27

mg/l

0.33

7263

26913

Disorders of the thyroid gland

16037

80467

1.41

254.69

3.5

3.2

455.69

414.19

mg/l

0.47

10152

51863

Peripheral artery disease

8341

47224

1.65

252.04

4.3

3.2

312.65

398.59

mg/l

1.46

6321

30160

First line medication for Crohn's disease

18801

79533

1.37

251.96

4.0

3.1

671.92

312.10

mg/l

14.32

12767

50393

Care involving use of rehabilitation procedures

11150

75825

1.50

251.90

3.6

3.1

808.91

366.93

mg/l

10.63

7617

47067

Implicit bacterial Sepsis

7695

47858

1.66

248.96

4.4

3.1

583.98

373.51

mg/l

3.34

5798

30176

Asthma

13694

53915

1.45

248.49

3.3

3.2

569.00

303.63

mg/l

6.45

8986

33714

Pneumonia, organism unspecified

15515

83935

1.41

247.72

3.8

3.2

564.36

353.43

mg/l

5.59

10861

52713

Missing teeth due to accident, extraction or parodontitis

10758

75466

1.53

247.62

3.6

3.2

466.06

409.31

mg/l

0.54

6614

47902

General symptoms and signs

18419

72043

1.37

247.53

3.5

3.2

548.99

338.46

mg/l

5.96

12392

45452

Other disorders of urethra and urinary system

11786

63160

1.48

246.62

3.7

3.2

492.10

430.85

mg/l

0.64

7766

39416

ILD medications: immunosuppressive drugs

10731

73418

1.50

246.50

5.3

3.1

835.05

317.52

mg/l

15.19

7734

46073

Other diseases of liver

3284

19120

2.20

244.43

3.7

3.2

265.74

410.32

mg/l

1.36

2277

12081

Vitreous haemorrhage

2066

10621

2.85

238.41

5.9

3.2

292.34

325.23

mg/l

0.19

1601

6877

Diarrhoea and gastroenteritis of presumed infectious origin

11504

77284

1.46

238.02

4.1

3.2

482.75

386.11

mg/l

1.36

8119

49360

Asthma (mode)

13447

54332

1.44

237.26

3.3

3.2

585.21

302.94

mg/l

6.87

8777

34013

Other dorsopathies, not elsewhere classified

16878

68622

1.38

236.88

3.3

552.21

322.13

mg/l

6.09

10994

44226

Diseases of pulp and periapical tissues and dental caries

11858

44959

1.48

235.84

3.3

3.1

332.88

420.46

mg/l

1.30

7739

28387

Cholecystectomy

12130

79175

1.46

235.44

3.3

3.2

418.44

429.45

mg/l

0.09

7764

49500

Oedema, not elsewhere classified

5915

39319

1.74

235.20

3.8

3.2

530.92

341.14

mg/l

2.15

4017

24398

Dental caries

4308

25758

1.89

234.64

5.1

3.2

773.72

361.29

mg/l

5.00

3205

16781

Chronic nephritic syndrome

949

3568

5.43

232.35

10.0

3.1

384.27

279.96

mg/l

0.53

866

2325

Other diseases of hard tissues of teeth

10594

40048

1.51

231.11

3.4

3.1

404.38

376.49

mg/l

0.23

6769

25626

Artrosis, including avohilmo

14213

59452

1.42

231.01

3.2

3.3

370.19

422.11

mg/l

0.64

9228

38401

Arthrosis

12548

51766

1.45

230.73

3.2

410.71

359.36

mg/l

0.56

8178

32847

Explicit Sepsis

7776

51576

1.61

230.16

4.4

3.1

607.17

377.03

mg/l

3.79

5814

32492

Caries of dentine

3852

22823

1.96

229.40

5.1

3.2

800.14

375.87

mg/l

4.57

2868

14909

Aplastic and other anaemias

8179

54998

1.59

225.44

4.4

3.2

800.93

374.50

mg/l

8.94

6046

34828

Diseases of liver

6060

41545

1.71

223.98

3.7

3.3

358.68

399.78

mg/l

0.32

4197

26514

Other and unspecified iron deficiency

5693

38335

1.73

223.97

3.9

3.2

441.47

447.47

mg/l

0.03

3983

24046

Septicaemia

7548

50222

1.61

223.89

4.5

3.1

613.09

346.65

mg/l

4.75

5637

31601

Other specific joint derangements/joint disorders

11547

55677

1.45

223.52

3.4

3.3

518.57

358.59

mg/l

2.46

7437

35855

Isolated proteinuria

733

2452

7.12

222.31

8.1

3.3

427.85

247.33

mg/l

1.46

675

1653

Iron deficiency anaemia

7194

50022

1.62

221.31

3.9

3.2

426.78

414.51

mg/l

0.08

4994

31425

Benign neoplasm of colon, rectum, anus and anal canal

11506

76328

1.47

218.77

3.6

3.2

492.57

404.51

mg/l

1.08

7771

47978

Asthma (only as main-diagnosis), excluding more controls

11700

50123

1.45

217.59

3.3

3.1

550.55

300.23

mg/l

5.16

7593

31039

Complications of medical and surgical care

12464

88088

1.43

216.90

3.6

3.2

604.23

390.25

mg/l

4.26

8377

55552

GASTRO-related operations

12943

48987

1.42

216.60

3.6

3.0

533.50

314.78

mg/l

4.68

8530

31051

Any gastric operation

12943

48987

1.42

216.60

3.6

3.0

533.50

314.78

mg/l

4.68

8530

31051

Nephrotic syndrome

756

2589

6.25

216.47

11.8

3.0

815.59

207.24

mg/l

4.72

704

1717

Implicit viral Sepsis

5114

34031

1.78

216.32

4.4

3.1

582.17

388.10

mg/l

1.94

3699

21325

Certain infectious and parasitic diseases

16634

65284

1.37

216.18

3.7

3.0

498.63

347.82

mg/l

3.33

11279

40319

Personality disorders, excluding more controls

3712

22467

1.89

215.83

3.3

404.24

419.58

mg/l

0.07

2380

14555

Other and unspecified anaemias

7533

51578

1.60

213.53

4.2

3.2

790.22

368.82

mg/l

8.23

5529

32705

Covid-19 confirmed case

6210

43107

1.66

211.35

4.0

3.3

575.29

413.83

mg/l

1.68

4338

27837

Cystic kidney disease

819

2980

5.58

211.00

7.8

3.2

189.64

164.15

mg/l

0.11

716

1932

Nutritional anaemias

8368

58861

1.54

210.57

3.9

3.2

457.82

412.26

mg/l

0.40

5782

37058

Other anaemias

7577

51930

1.59

210.15

4.2

3.2

786.77

371.81

mg/l

8.06

5554

32911

Asthma (diagnoses ohter than nonallergic)

14272

92526

1.38

209.75

3.2

3.3

552.90

394.82

mg/l

2.84

9251

59200

Gastro-oesophageal reflux disease

11715

77351

1.44

209.21

3.4

3.2

552.65

372.80

mg/l

2.78

7080

49136

Cystic kidney disease

773

2744

5.93

208.89

8.1

3.3

194.54

172.28

mg/l

0.09

685

1788

Any death

7043

69473

0.64

208.65

3.2

3.3

726.21

361.55

mg/l

6.69

4915

43943

Polycystic kidney disease

683

2285

7.37

208.61

8.3

3.3

151.97

193.91

mg/l

0.18

615

1499

Other arrhythmias

10555

59732

1.46

208.18

3.2

525.36

396.04

mg/l

1.52

6458

36947

Concussion

7552

43530

1.54

207.80

3.2

448.82

335.62

mg/l

1.18

4914

27350

Other septicaemia

6726

45727

1.63

207.79

4.5

3.1

589.43

359.83

mg/l

3.46

5048

28808

Benign neoplasms

16140

69998

1.36

206.59

3.5

3.2

467.62

370.41

mg/l

1.61

10852

45584

Mood disorders, excluding more controls

15959

75242

1.36

205.31

3.4

3.3

406.73

402.49

mg/l

0.04

10273

48003

Diseases of oral cavity, salivary glands and jaws

10544

40267

1.47

205.08

3.3

3.1

364.85

374.88

mg/l

0.08

6844

25769

Fever of other and unknown origin

9406

62103

1.48

203.95

4.0

3.2

699.17

333.70

mg/l

8.20

6680

39168

Lumbar disc prolapse

10902

63375

1.45

203.16

3.3

548.16

324.33

mg/l

4.00

7111

40370

Dizziness and giddiness

12834

78969

1.41

202.39

3.3

524.92

401.34

mg/l

1.78

8190

50167

Unspecified mental disorder

6233

43254

1.62

202.02

3.2

3.3

436.67

410.72

mg/l

0.15

3888

28053

Chronic lower respiratory diseases

20040

86380

1.31

201.98

3.3

522.12

386.86

mg/l

2.96

13108

55373

Implicit viral Sepsis

3595

22469

1.95

201.60

4.8

3.1

717.25

357.06

mg/l

3.46

2671

14187

Viral Sepsis

3600

22513

1.95

201.41

4.8

3.1

716.35

356.30

mg/l

3.47

2675

14221

Disease of hard tissues of teeth, NOS

10030

38942

1.49

201.11

3.4

3.1

408.12

372.89

mg/l

0.28

6232

24902

Other disorders of ear

15754

81888

1.36

200.80

3.4

3.3

444.13

398.11

mg/l

0.53

9768

52569

Kela-code for severe mental illness

5675

38808

1.65

199.97

3.2

3.3

390.31

422.01

mg/l

0.19

3532

25155

Myocardial infarction, without ST-elevation

7356

48707

1.60

198.97

3.6

3.3

349.60

403.40

mg/l

0.56

5186

31660

Gonarthrosis, primary, with knee surgery

10450

63687

1.47

196.10

3.2

3.3

382.47

431.97

mg/l

0.48

6455

40083

Unstable angina pectoris

6654

37411

1.63

195.26

3.4

3.2

556.60

419.44

mg/l

1.32

4612

23515

Factors influencing health status and contact with health services

5335

17551

1.68

194.03

3.5

2.8

351.91

292.38

mg/l

0.44

3583

11102

Use of hypnotics and sedatives

18097

83846

1.33

193.33

3.4

3.3

522.73

380.91

mg/l

2.92

11487

54089

Other disorders of kidney and ureter

2472

14373

2.31

192.97

6.4

3.2

637.29

326.88

mg/l

2.48

1988

9237

Asthma, including avohilmo

19593

89539

1.31

189.98

3.2

3.3

499.01

397.09

mg/l

1.86

12676

57640

Familial hypercholesterolemia

2864

17310

2.12

189.48

3.9

3.1

286.48

351.61

mg/l

0.39

2002

10904

Sciatica+with lumbago

8546

58370

1.49

188.01

3.3

508.89

331.09

mg/l

2.41

5615

36859

Maternal care for other conditions predominantly related to pregnancy

2289

12147

2.08

187.76

3.5

3.1

245.85

575.34

mg/l

3.40

1496

7164

Unspecified haematuria

7599

46207

1.55

187.28

3.8

3.3

368.33

385.04

mg/l

0.13

5499

30140

Primary gonarthrosis, bilateral

9184

59722

1.49

183.62

3.2

348.06

427.42

mg/l

0.92

5671

37378

Congenital malformations of the urinary system

1141

5056

3.30

183.50

7.0

3.3

218.95

290.16

mg/l

0.36

957

3296

Coronary artery bypass grafting

4878

24791

1.76

183.01

3.7

3.2

277.61

377.00

mg/l

1.16

3593

16073

Abnormal findings on examination of blood, without diagnosis

8230

56486

1.52

182.59

3.7

3.3

711.65

362.07

mg/l

6.56

5892

37198

Artificial joint operation, meniscal resection

15954

83511

1.34

181.55

3.2

3.3

384.46

420.63

mg/l

0.42

10094

53314

Congenital malformations of the urinary system

1075

4670

3.39

180.71

7.3

3.3

225.15

265.72

mg/l

0.18

917

3047

Disorders of other endocrine glands

6754

47821

1.55

179.67

4.0

3.2

499.65

421.65

mg/l

0.63

4597

30001

Arthropathies in other diseases classified elsewhere

831

3297

4.55

179.30

6.2

3.2

350.43

382.73

mg/l

0.10

650

2094

Spondylosis

9458

58593

1.46

179.30

3.2

460.32

319.21

mg/l

1.94

6061

37014

Other maternal disorders predominantly related to pregnancy

7378

33181

1.52

179.14

3.6

3.1

406.34

511.76

mg/l

0.98

4726

18719

Selective serotonin reuptake inhibitors

16932

71130

1.32

178.95

3.3

359.34

403.07

mg/l

0.58

10785

46231

Trigger finger

2559

15100

2.12

178.93

4.4

3.2

190.90

379.13

mg/l

2.30

1728

9284

Disorders of eyelid, lacrimal system and orbit

14247

86281

1.35

178.56

3.3

491.78

409.52

mg/l

1.05

8861

55017

Chronic pancreatitis

2334

13635

2.27

177.90

4.2

3.2

321.92

399.44

mg/l

0.43

1684

8976

Asthma (only as main-diagnosis)

12028

53915

1.39

177.88

3.3

3.2

547.11

303.63

mg/l

5.09

7785

33714

Benzodiazepine use

16638

92742

1.32

176.22

3.2

3.3

436.98

408.17

mg/l

0.30

10250

59967

Conductive and sensorineural hearing loss

13869

74580

1.36

175.80

3.3

3.2

438.55

397.37

mg/l

0.42

8555

47749

Cutaneous abscess, furuncle and carbuncle

4115

27152

1.75

175.62

4.1

3.3

499.32

386.93

mg/l

0.78

2973

17674

Constipation

15001

83396

1.34

174.85

3.4

3.2

623.80

379.18

mg/l

5.39

9251

53358

Mood disorders

16710

87611

1.31

173.22

3.4

3.3

406.31

418.77

mg/l

0.12

10772

55934

Haemorrhage from respiratory passages

6050

38931

1.59

172.76

3.6

3.2

494.57

387.58

mg/l

0.93

4122

24912

Valvular heart disease excluding rheumatic fever

8156

43977

1.50

172.30

3.5

3.2

521.12

387.11

mg/l

1.54

5437

27214

Non-rheumatic valve diseases

8135

43838

1.50

171.89

3.6

3.2

521.84

386.37

mg/l

1.56

5421

27118

Mood [affective] disorders

16657

87549

1.31

171.36

3.4

3.3

407.62

418.95

mg/l

0.11

10733

55894

Other arthrosis

9117

47803

1.46

171.35

3.2

451.10

360.80

mg/l

0.93

5794

30153

Disorders of synovium and tendon

8653

57000

1.46

171.27

3.7

3.2

537.93

358.52

mg/l

2.34

5618

35812

Sensorineural hearing loss

13322

72084

1.37

170.16

3.4

3.2

453.39

398.13

mg/l

0.60

8227

46086

Schizophrenia or delusion, excluding more controls

4579

30628

1.66

168.74

3.2

3.3

371.65

389.19

mg/l

0.09

2854

19711

Conduction disorders

5217

29529

1.65

168.09

3.6

3.2

373.06

390.53

mg/l

0.10

3514

18404

Benign neoplasm: Colon

9616

71204

1.45

167.34

3.6

3.2

466.27

410.65

mg/l

0.52

6532

44899

Other and unspecified polyneuropathies, also in other diseases

3461

22660

1.90

167.11

4.6

3.2

1659.22

333.95

mg/l

15.34

2523

14790

Abnormal findings on examination of urine, without diagnosis

926

3985

3.84

166.92

7.0

3.3

463.97

251.36

mg/l

1.48

823

2645

Hernia of abdominal wall, postoperative

3401

21950

1.86

166.79

3.8

3.0

484.52

275.56

mg/l

1.71

2316

13952

Heart failure and bmi 25plus

6967

34979

1.59

166.59

4.0

3.3

354.66

345.36

mg/l

0.07

5039

21719

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

5874

20287

1.57

165.82

3.4

3.1

403.75

226.96

mg/l

2.16

3865

12678

Certain disorders involving the immune mechanism

3169

20186

1.90

164.78

5.3

3.2

750.03

404.75

mg/l

2.75

2327

12959

Coxarthrosis

8901

44586

1.46

164.57

3.2

3.1

440.38

358.73

mg/l

0.83

5738

28062

Fall on same level

18740

84096

1.29

163.27

3.4

3.3

410.64

404.86

mg/l

0.06

12133

54253

Hyperkalaemia

1132

5306

3.15

162.84

5.3

3.1

505.82

288.62

mg/l

1.15

912

3401

Bacterial infection, other or unspecified

9810

64208

1.42

162.69

4.2

3.1

707.81

364.18

mg/l

8.01

7078

39912

Pain in joint

9685

47149

1.42

161.87

3.4

3.2

485.61

282.39

mg/l

3.40

6245

30175

Dorsopathies

16681

68740

1.30

161.64

3.3

535.85

322.90

mg/l

5.41

10804

44327

Other diseases of urinary system

16574

75814

1.31

161.52

3.7

3.2

396.44

413.37

mg/l

0.18

11152

48247

Disorders of adult personality and behaviour

3892

25575

1.71

161.33

3.3

3.4

442.25

436.01

mg/l

0.03

2471

16725

Non-ischemic cardiomyopathy

5273

30026

1.64

161.09

3.8

3.1

494.27

428.85

mg/l

0.46

3748

18394

Pain (limb, back, neck, head abdominally)

12411

48776

1.36

159.14

3.4

3.2

510.68

283.37

mg/l

5.15

8262

31287

Asthma/COPD (KELA code 203)

15496

86275

1.31

158.18

3.2

3.3

529.62

387.26

mg/l

2.56

9917

55295

Non-selective monoamine reuptake inhibitors

6392

45131

1.53

157.39

3.3

3.2

352.76

420.33

mg/l

0.56

4033

27889

Arthropathies

14122

57042

1.33

156.64

3.5

3.2

420.63

354.42

mg/l

0.89

9399

36839

Atherosclerosis, excluding cerebral and coronary sclerosis

7422

44251

1.51

156.57

4.2

3.2

320.19

393.02

mg/l

1.03

5585

28278

Provisional assignment of new diseases of uncertain etiology

8179

61976

1.44

155.26

3.7

3.3

498.99

418.16

mg/l

0.80

5565

40016

Codes for special purposes

8189

62071

1.44

155.12

3.7

3.3

498.59

418.74

mg/l

0.78

5571

40074

Personality disorders

3712

24406

1.71

154.18

3.3

3.4

404.24

421.49

mg/l

0.08

2380

15913

Hernia of abdominal wall

7678

58224

1.48

154.11

3.6

3.3

406.64

406.79

mg/l

0.00

5263

37702

Depression or dysthymia

11697

50786

1.37

153.70

3.4

3.3

394.87

382.22

mg/l

0.10

7568

32700

Mixed hyperlipidaemia

864

3754

3.80

152.93

4.4

3.1

186.64

234.89

mg/l

0.21

634

2406

Coxarthrosis [arthrosis of hip](FG)

9629

52624

1.42

152.27

3.2

3.1

458.11

363.07

mg/l

1.07

6169

32812

Depression

15200

83816

1.31

152.26

3.4

3.3

403.85

417.76

mg/l

0.13

9824

53371

Abdominal and pelvic pain

16950

69676

1.29

151.83

3.5

3.2

477.40

373.32

mg/l

1.81

11233

44607

Intestinal infectious diseases

15077

93203

1.30

151.69

4.1

3.2

557.88

390.32

mg/l

3.65

10561

59109

Malaise and fatigue

8601

52928

1.43

151.61

3.4

3.2

530.06

350.29

mg/l

2.58

5769

33084

Diseases of the musculoskeletal system and connective tissue

8254

30754

1.43

150.65

3.4

3.2

368.86

248.46

mg/l

1.69

5521

19793

Pacemaker

5728

40131

1.58

150.58

3.4

3.2

474.59

396.79

mg/l

0.59

3947

25955

Polyneuropathies and other disorders of the peripheral nervous system

3806

25944

1.77

149.78

4.5

3.2

1647.03

329.11

mg/l

16.62

2755

16927

Polycystic ovarian syndrome, consortium definition

9766

44507

1.39

149.68

3.4

3.1

456.31

483.48

mg/l

0.19

5801

25844

Idiopathic gout

1813

10468

2.42

149.38

4.4

3.2

318.79

289.83

mg/l

0.14

1386

6969

Certain infectious and parasitic diseases

12552

49786

1.34

149.28

3.5

3.0

458.63

350.75

mg/l

1.60

8403

30620

Bipolar affective disorders

2634

16162

1.87

147.02

3.3

539.09

438.62

mg/l

0.41

1682

10508

Drug-induced hypoglycaemia without coma

424

1300

8.10

146.51

5.4

3.3

197.27

198.58

mg/l

0.00

327

882

Other joint disorders

13505

56998

1.32

146.23

3.3

3.2

462.10

354.71

mg/l

1.59

8765

36802

AV-block

3234

18597

1.82

144.81

3.6

3.2

426.14

342.12

mg/l

0.49

2263

11775

Acute pancreatitis

3340

22174

1.79

144.54

3.7

3.2

431.77

390.74

mg/l

0.19

2277

14406

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

10051

78340

1.38

144.20

3.6

3.2

631.46

388.74

mg/l

4.29

6764

49431

Asthma, hospital admission 2, infections

9040

68710

1.39

143.18

3.4

3.3

605.54

390.47

mg/l

3.20

6077

43772

Asthma-related infections

9040

68710

1.39

143.18

3.4

3.3

605.54

390.47

mg/l

3.20

6077

43772

Nausea and vomiting

4313

29250

1.63

143.06

4.1

3.2

456.44

400.19

mg/l

0.34

3025

18127

Autoimmune diseases related-to ILD

13537

94198

1.31

141.45

3.8

3.2

557.32

392.03

mg/l

3.04

9029

60102

Mycoses

13499

95538

1.31

141.38

3.4

3.3

401.37

413.83

mg/l

0.11

8704

61349

Persons encountering health services in other circumstances

6101

44750

1.49

138.83

3.7

3.2

378.21

462.61

mg/l

0.76

3939

27811

Dermatitis

9875

77809

1.37

138.50

3.7

3.2

537.85

397.02

mg/l

1.84

6579

49211

Gastrointestinal diseases

9096

34826

1.39

138.08

3.4

3.1

450.89

300.11

mg/l

2.09

5934

21983

Symptoms and signs involving the digestive system and abdomen

16838

69676

1.28

137.57

3.5

3.2

518.78

373.32

mg/l

2.93

11177

44607

Peripheral arterial reconstruction

3043

20204

1.85

137.54

4.3

3.2

353.90

353.88

mg/l

0.00

2310

13243

Bacterial infection, other or unspecified

8985

61123

1.40

136.11

4.2

3.1

705.32

361.97

mg/l

7.53

6473

38106

Meniscus derangement

9350

49291

1.39

135.47

3.2

400.54

356.12

mg/l

0.38

5929

31246

Schizophrenia or delusion

4579

32438

1.57

132.71

3.2

3.3

371.65

409.92

mg/l

0.21

2854

21042

Diseases of the ear and mastoid process

18683

78512

1.25

131.86

3.5

3.3

441.44

397.03

mg/l

0.56

11909

50822

Redundant prepuce, phimosis and paraphimosis

3285

21757

1.72

131.29

3.8

3.4

343.96

354.72

mg/l

0.05

2421

15335

Mouth breathing

6439

48630

1.48

131.23

3.4

3.3

468.84

390.62

mg/l

0.62

4405

31805

Extreme obesity with alveolar hypoventilation

825

3770

3.51

130.55

3.5

3.2

513.41

353.48

mg/l

0.39

544

2363

Specific personality disorders

3128

20559

1.71

129.82

3.3

3.4

489.12

449.67

mg/l

0.15

1986

13441

Schizophrenia, schizotypal and delusional disorders

4589

32662

1.56

129.53

3.2

3.3

355.59

419.98

mg/l

0.42

2861

21175

Any mental disorder

18341

76972

1.26

129.22

3.3

453.15

402.35

mg/l

0.67

11925

49221

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

3606

24266

1.63

128.44

3.3

549.93

413.63

mg/l

0.78

2310

15717

Malignant neoplasm of respiratory system and intrathoracic organs

1638

22984

0.51

127.70

3.0

3.3

530.08

273.16

mg/l

1.29

1079

14933

Adhesive capsulitis of shoulder

2841

18744

1.81

126.73

4.1

3.2

269.83

386.63

mg/l

0.93

2029

11563

Follow-up examination after treatment for conditions other than malignant neoplasms

6607

32680

1.44

126.03

3.4

2.9

299.41

345.51

mg/l

0.40

4273

20310

Other headache syndromes

6009

44784

1.46

125.09

3.1

3.2

627.61

445.67

mg/l

1.47

3628

27357

Diabetic retinopathy, excluding more controls

8578

40667

1.72

124.71

5.3

3.5

218.32

120.81

mg/l

3.01

6321

26953

Intestinal infectious diseases

18623

89867

1.24

122.73

3.8

3.2

488.74

394.37

mg/l

1.74

12651

56901

Acute pancreatitis (for exclusion)

3340

22993

1.71

121.84

3.7

3.3

431.77

400.50

mg/l

0.14

2277

15032

6350

47583

1.44

121.59

3.4

3.3

522.10

396.76

mg/l

1.11

4188

30282

Degeneration of macula and posterior pole

8130

51006

1.41

120.63

3.5

3.1

433.61

407.49

mg/l

0.19

5114

31932

Abnormalities of heart beat

5480

39838

1.48

120.58

3.3

3.2

534.20

401.83

mg/l

1.00

3474

25000

Viral and other specified intestinal infections

3398

22079

1.62

120.34

4.5

3.2

520.05

396.69

mg/l

0.76

2474

14519

Amputation of toe

1349

7576

2.48

120.28

5.5

3.3

414.21

240.64

mg/l

1.18

1105

5013

Hernia

15130

84615

1.27

119.03

3.3

482.20

401.94

mg/l

1.09

9812

53718

Necrosis of pulp, including avohilmo

8544

67322

1.36

118.26

3.4

3.3

503.23

392.60

mg/l

1.14

5538

43421

Amputation

1787

10812

2.11

117.78

5.3

3.2

383.81

319.00

mg/l

0.39

1444

7071

Other neurological diseases

11979

77329

1.31

117.47

3.3

555.92

404.72

mg/l

2.30

7965

48943

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

9201

73662

1.35

116.68

3.6

3.2

640.48

400.40

mg/l

3.85

6201

46532

Cough

6331

45592

1.43

116.60

3.4

3.2

395.61

402.17

mg/l

0.04

3985

28558

Viral and other specified intestinal infections

2533

15725

1.73

116.49

4.8

3.3

528.22

361.94

mg/l

0.98

1884

10473

Operations 2 for CAVS

5016

36261

1.53

116.09

3.7

3.2

531.28

370.92

mg/l

1.50

3612

23447

Calcific aortic valvular stenosis, diagnosis (helper)

5016

36261

1.53

116.09

3.7

3.2

531.28

370.92

mg/l

1.50

3612

23447

Calcific aortic valvular stenosis

5020

36296

1.53

116.06

3.7

3.2

531.14

370.63

mg/l

1.50

3613

23474

Calcific aortic valvular stenosis, operated

5020

36296

1.53

116.06

3.7

3.2

531.14

370.63

mg/l

1.50

3613

23474

Malignant neoplasm of bronchus and lung

1392

19821

0.50

115.28

3.0

3.3

480.73

257.32

mg/l

1.02

917

12853

COPD/asthma/ILD related infections

16876

71031

1.25

114.85

3.6

3.2

558.66

348.78

mg/l

5.40

11272

44208

COPD/asthma related infections

16876

71031

1.25

114.85

3.6

3.2

558.66

348.78

mg/l

5.40

11272

44208

Calcific aortic valvular stenosis, including rheumatic fever

5027

36395

1.53

114.41

3.7

3.2

530.23

369.89

mg/l

1.51

3621

23528

Substance abuse, excluding more controls

8780

59440

1.35

114.27

3.4

3.3

338.10

381.40

mg/l

0.44

5895

39312

Oter anti-inflammatory and antirheumatic agents, non-steroids

3841

14736

1.62

113.91

3.2

3.5

394.24

428.49

mg/l

0.16

2483

9844

Recurrent or chronic depression

5993

31601

1.44

113.54

3.3

361.25

393.35

mg/l

0.21

3854

19856

Other pulmonary diagnosis

13225

54469

1.28

113.02

3.4

3.2

516.91

307.18

mg/l

4.64

8719

34070

Other and unspecified dermatitis

8030

63487

1.37

112.90

3.7

3.2

516.42

402.81

mg/l

1.15

5338

39948

Asthma, hospital admissions , main diagnosis only

12551

91527

1.28

111.50

3.2

3.3

542.60

400.76

mg/l

2.15

8111

58442

Peripheral artery operations in Hilmo

2203

14155

1.89

111.38

5.0

3.2

363.91

344.31

mg/l

0.10

1736

9225

Cerebrovascular diseases

12575

73545

1.29

108.32

3.5

3.2

455.09

406.54

mg/l

0.53

8486

46403

Excluding asthma or asthma-COPD overlap

13172

54469

1.28

108.10

3.4

3.2

519.93

307.18

mg/l

4.72

8675

34070

Cellulitis

3386

23808

1.62

106.51

4.2

3.2

387.23

374.11

mg/l

0.06

2459

15482

Candidiasis

4117

29869

1.53

105.83

3.7

3.2

585.71

430.40

mg/l

0.98

2644

18522

COPD differential diagnosis

13117

54341

1.27

105.65

3.4

3.2

522.89

302.89

mg/l

4.95

8623

34020

18551

81854

1.23

105.41

3.6

3.2

536.31

376.09

mg/l

3.72

12209

51705

Malignant neoplasm of bronchus and lung, including Hilmo

1808

23786

0.56

105.37

3.1

3.3

516.95

283.36

mg/l

1.23

1211

15402

ILD differential diagnosis

13111

54332

1.27

105.26

3.4

3.2

522.99

302.94

mg/l

4.95

8621

34013

Headache

9958

64558

1.30

103.30

3.3

3.2

578.14

349.35

mg/l

3.69

6389

40248

Poisoning by drugs, medicaments and biological substances

3137

21665

1.60

102.59

3.3

427.16

433.23

mg/l

0.02

2029

14099

Disorders of skin appendages

6719

52347

1.38

102.16

3.7

3.3

564.51

392.16

mg/l

1.81

4510

33491

Other reaction to severe stress, and adjustment disorders

4753

35190

1.46

102.14

3.7

3.3

393.74

420.45

mg/l

0.15

3198

22343

Oxicams

3863

15547

1.56

101.99

3.2

3.6

367.39

425.94

mg/l

0.33

2566

10454

Syncope and collapse

7430

50369

1.37

101.26

3.4

3.2

360.12

345.19

mg/l

0.11

4880

31722

Injuries to the knee and lower leg

18895

90114

1.22

100.66

3.4

3.3

414.87

415.06

mg/l

0.00

12344

57699

Umbilical hernia

4439

33154

1.51

99.80

3.7

3.4

344.75

344.74

mg/l

0.00

3061

22144

Psychiatric diseases

16404

69826

1.23

98.30

3.3

482.95

391.00

mg/l

1.41

10681

44623

All influenza

3907

28555

1.53

97.04

3.9

3.2

672.06

349.04

mg/l

3.04

2714

18412

Any operation in hilmo

540

979

3.12

96.14

3.4

2.4

310.86

89.03

mg/l

0.67

375

630

Excessive, frequent and irregular menstruation

4974

20220

1.44

95.11

3.3

3.2

547.21

470.93

mg/l

0.40

2982

12010

Familial hypercholesterolemia, with ischemic heart disease

1631

10243

2.03

94.93

4.0

3.2

255.54

380.43

mg/l

0.71

1162

6546

Falls/tendency to fall

17258

73937

1.22

94.23

3.4

3.3

443.56

395.00

mg/l

0.62

11211

47719

9438

68124

1.30

93.68

3.4

315.65

392.01

mg/l

1.09

6416

45396

Poisoning by medicine

2806

19307

1.61

93.58

3.3

391.24

449.45

mg/l

0.27

1829

12588

Other functional intestinal disorders

7008

51600

1.36

93.55

3.5

3.2

706.35

378.33

mg/l

4.40

4490

32469

Other/unspecified dorsalgia

5607

42903

1.40

93.50

3.3

640.08

345.24

mg/l

3.28

3662

27022

Coxibs

4312

16522

1.49

93.41

3.1

3.7

422.20

410.72

mg/l

0.05

2812

11226

Thyroiditis, ILD-related definition

1663

10299

1.90

93.24

4.4

3.2

152.50

372.98

mg/l

2.45

1093

6325

Injuries to the head

17427

92143

1.21

92.96

3.4

3.3

427.71

412.64

mg/l

0.15

11312

59151

Other diseases of pancreas

1425

8696

2.12

92.90

4.0

3.2

288.30

278.31

mg/l

0.03

980

5528

Acute sinusitis

7336

54051

1.34

92.65

3.7

3.2

575.70

362.34

mg/l

2.66

4824

34418

Other and unspecified nonorganic psychotic disorders

2474

16619

1.66

92.64

3.1

3.4

521.09

444.49

mg/l

0.27

1518

10929

Diabetic retinopathy, strict definition

5108

37548

1.82

92.63

6.3

3.7

218.16

143.50

mg/l

1.89

3921

26208

Chronic gastritis

4481

33935

1.48

91.79

3.6

3.2

452.06

360.21

mg/l

0.63

2931

21164

Diseases of the digestive system

7181

57241

1.35

91.42

3.8

3.2

534.29

403.85

mg/l

1.37

4938

36845

Schizophrenia

2310

15489

1.71

91.08

3.2

3.4

339.05

413.71

mg/l

0.33

1440

10214

Status post-ami

4381

25136

1.50

91.06

3.6

3.2

360.62

388.48

mg/l

0.17

3129

16152

Glaucoma

9273

65814

1.31

90.52

3.5

3.2

483.49

416.91

mg/l

0.61

5786

41475

Menorrhagia

4638

19139

1.45

89.65

3.2

3.1

434.39

481.88

mg/l

0.24

2741

11168

Alcohol-induced chronic pancreatitis

1143

6649

2.31

89.58

4.2

3.3

380.21

286.36

mg/l

0.32

823

4528

Alcohol use disorder, Swedish definition

8583

64351

1.31

88.34

3.4

320.01

390.88

mg/l

0.90

5836

43038

Hypokalaemia

1850

12005

1.82

87.53

3.5

3.0

511.72

361.12

mg/l

0.66

1280

7248

Anaemia in chronic diseases classified elsewhere

498

2199

3.88

87.04

8.9

3.2

572.45

160.83

mg/l

1.96

452

1429

Other gastritis (incl. Duodenitis)

3628

26816

1.53

87.00

3.7

3.2

512.35

358.70

mg/l

1.09

2506

17003

Volume depletion

1461

8943

1.96

86.98

4.2

3.1

336.08

355.78

mg/l

0.07

1086

5692

Exclusions for E4_PCOS_CONSORTIUM

9735

50043

1.28

86.86

3.2

468.76

449.71

mg/l

0.12

5774

30581

Other specified/unspecified arthritis

4007

29867

1.48

86.84

3.6

3.2

723.40

385.27

mg/l

2.99

2691

18678

Cystitis

13084

65731

1.24

86.51

3.5

3.2

332.77

424.69

mg/l

1.61

8720

41226

4797

32162

1.45

86.49

3.3

3.1

423.20

409.10

mg/l

0.07

2968

20236

Pure hyperglyceridaemia

458

1932

3.87

85.70

4.4

3.1

154.84

221.47

mg/l

0.26

348

1238

Fibromyalgia

1245

7266

2.02

85.43

2.8

3.1

839.17

425.27

mg/l

1.25

745

4258

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

3606

26297

1.48

85.37

3.3

3.4

549.93

420.85

mg/l

0.72

2310

17143

Diarrhoea and gastroenteritis of presumed infectious origin

15790

89525

1.21

85.22

3.8

3.2

426.45

395.67

mg/l

0.35

10874

56576

Exposure to unspecified factor

15381

95180

1.22

84.65

3.4

3.3

464.35

407.43

mg/l

0.71

9886

61220

ILD medications: azathioprine

2099

13991

1.71

84.27

5.8

3.1

494.95

312.51

mg/l

1.07

1616

8904

Diabetic maculopathy

3679

28196

1.98

84.13

6.2

3.7

195.60

136.00

mg/l

1.31

2941

19797

Osteomyelitis

1104

6442

2.23

83.63

5.4

3.3

343.97

286.18

mg/l

0.27

890

4295

Mental and behavioural disorders due to psychoactive substance use

9091

69642

1.28

82.82

3.4

354.33

394.15

mg/l

0.40

6096

46329

Other arthritis (FG)

4563

34896

1.43

82.75

3.6

3.2

718.30

354.24

mg/l

3.87

3070

21850

Dermatitis and eczema

17294

93007

1.20

82.58

3.6

3.3

524.04

392.70

mg/l

2.53

11239

59670

Hypo-osmolality and hyponatraemia

2682

18886

1.62

82.22

3.8

3.0

616.55

407.45

mg/l

1.16

1783

11512

8942

66783

1.29

82.12

3.4

329.62

390.41

mg/l

0.74

6096

44601

Asthma-related pneumonia or sepsis

5443

42625

1.38

81.63

3.5

3.2

685.08

410.25

mg/l

3.01

3811

27011

Asthma, hospital admissions 3, pneumonia

5443

42625

1.38

81.63

3.5

3.2

685.08

410.25

mg/l

3.01

3811

27011

Diabetic retinopathy

10364

57190

1.46

81.36

5.2

3.7

225.17

151.56

mg/l

2.09

7614

39588

Asthma-related pneumonia

5431

42547

1.38

81.24

3.5

3.2

686.28

410.86

mg/l

3.01

3804

26964

Cervical disc disorders

5757

45684

1.37

80.48

3.2

3.3

659.67

329.26

mg/l

3.87

3688

28788

Acidosis

435

1868

3.99

80.35

4.9

3.1

108.47

293.89

mg/l

1.35

337

1201

Symptoms and signs involving the nervous and musculoskeletal systems

8796

72893

1.29

79.89

3.4

3.3

871.35

391.60

mg/l

9.01

5997

46233

Presence of other devices

3751

28073

1.48

79.50

3.6

3.1

499.04

397.28

mg/l

0.61

2676

17839

Diseases of male genital organs

8309

34200

1.31

79.29

3.7

3.4

426.00

329.97

mg/l

1.07

5887

24063

Mixed and other personality disorders

1097

6330

2.06

79.05

3.3

294.58

359.60

mg/l

0.20

693

4145

Emotionally unstable personality disorder

1391

8452

1.84

78.58

3.2

3.3

522.84

405.81

mg/l

0.34

902

5563

Disorders of mineral metabolism

1297

7957

1.99

78.28

4.4

3.0

1114.86

342.49

mg/l

3.55

945

4924

Pain, not elsewhere classified

4075

30879

1.44

77.99

3.4

3.2

560.54

346.75

mg/l

1.72

2795

19203

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

10555

79852

1.26

77.82

3.5

3.2

673.41

396.56

mg/l

5.17

6966

50521

Anosmia

269

800

4.06

77.01

3.4

1.5

51.80

716.61

mg/l

1.68

158

375

Azathioprine

2099

14263

1.67

76.98

5.8

3.2

494.95

343.76

mg/l

0.81

1616

9148

Disorders of parathyroid gland

3161

23014

1.53

76.92

4.6

3.1

619.56

415.23

mg/l

1.27

2159

13773

Papulosquamous disorders

5961

47765

1.36

76.72

3.4

3.3

517.23

404.85

mg/l

0.90

3868

30155

Substance abuse

8780

68552

1.28

76.16

3.4

338.10

390.83

mg/l

0.58

5895

45665

Ventral hernia

3779

28722

1.47

75.33

3.6

3.3

474.28

370.71

mg/l

0.63

2576

18219

Disorders of vitreous body and globe

8229

65809

1.30

75.15

3.9

3.2

366.57

423.63

mg/l

0.57

5269

40867

Other disorders of skin and subcutaneous tissue, not elsewhere classified

2207

15369

1.66

75.06

4.5

3.1

541.12

355.74

mg/l

0.98

1550

9710

Acetic acid derivatives and related substances

4216

16433

1.43

74.59

3.2

3.7

235.21

409.11

mg/l

2.32

2753

11149

Lung transplantation

206

631

10.55

74.56

4.8

3.5

72.15

160.05

mg/l

0.40

163

419

Disorders of vitreous body

8017

64391

1.30

74.48

3.9

3.2

374.80

423.84

mg/l

0.45

5129

39924

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2292

15466

1.61

74.00

5.1

3.3

375.06

382.50

mg/l

0.03

1708

10165

Lung transplant status

205

630

10.59

73.96

4.8

3.5

72.51

160.05

mg/l

0.40

162

419

Symptoms and signs involving the skin and subcutaneous tissue

10628

88196

1.24

73.89

3.5

3.3

539.15

406.89

mg/l

1.72

6856

55944

Injuries to the shoulder and upper arm

13167

91385

1.22

73.36

3.4

3.3

424.61

410.06

mg/l

0.13

8585

58557

Viral infections characterized by skin and mucous membrane lesions

12936

95081

1.22

73.30

3.7

3.3

467.46

408.17

mg/l

0.68

8494

60807

Disorders of calcium metabolism

1009

5911

2.15

73.23

4.6

3.1

1154.60

276.17

mg/l

3.62

754

3621

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2033

13776

1.64

73.21

3.2

3.4

439.89

440.04

mg/l

0.00

1279

9038

Schizoaffective disorder

1067

6274

2.04

72.83

3.2

3.3

484.09

369.15

mg/l

0.28

685

4042

Hyperparathyroidism

2799

20185

1.56

72.81

4.8

3.1

600.60

415.60

mg/l

1.04

1938

12115

Cirrhosis of liver, NAS

948

5585

2.31

72.52

3.8

3.3

305.01

267.27

mg/l

0.13

702

3634

Other necrotizing vasculopathies (FG)

1003

5927

2.17

72.19

6.5

3.1

409.76

279.59

mg/l

0.48

752

3645

Systemic connective tissue disorders

5174

41047

1.37

72.10

4.1

3.2

759.70

412.23

mg/l

3.69

3434

25146

Periapical abscess

6684

54502

1.32

72.02

3.4

3.3

414.27

413.64

mg/l

0.00

4385

35066

Suicide or other Intentional self-harm

3164

23325

1.48

71.69

3.2

3.3

531.83

414.45

mg/l

0.58

1985

15135

Isolated proteinuria with specified morphological lesion

267

962

5.98

71.43

9.8

3.1

635.74

106.76

mg/l

2.45

250

624

Other and unspecified nerve root and plexus disorders, also in other diseases

2857

20933

1.52

70.37

3.3

3.2

966.93

407.87

mg/l

3.51

1741

13315

Visual disturbances and blindness

7697

63760

1.29

70.28

3.5

3.3

616.62

413.50

mg/l

2.33

4842

40450

Glaucoma suspect

5660

45713

1.36

70.15

3.6

3.2

582.23

414.82

mg/l

1.39

3481

28407

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

1184

7246

1.94

70.04

4.2

3.1

447.72

474.01

mg/l

0.07

829

4074

Transient ischemic attack

8593

58376

1.28

69.80

3.3

457.96

406.28

mg/l

0.43

5706

36724

6617

49858

1.33

69.69

3.5

3.2

422.01

408.22

mg/l

0.08

4165

31513

Polyarthrosis

3155

21882

1.50

69.60

3.2

3.1

850.23

379.63

mg/l

3.16

1859

12901

Viral infections characterized by skin and mucous membrane lesions

5992

48359

1.33

69.53

4.1

3.2

559.67

401.52

mg/l

1.52

4115

30976

Rheumatism, unspecified

2025

14030

1.66

69.52

3.2

3.1

870.54

379.20

mg/l

2.31

1216

8008

Dental pulpitis, including avohilmo

13306

74462

1.21

69.23

3.4

3.3

373.88

415.80

mg/l

0.47

8731

47918

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2125

14294

1.61

69.05

5.3

3.3

363.70

364.81

mg/l

0.00

1613

9419

Soft tissue disorders related to use, overuse and pressure

4118

31953

1.41

68.72

3.3

3.2

448.45

356.33

mg/l

0.59

2706

19824

Lupus nephritis

112

215

18.68

68.69

14.9

2.7

210.43

92.09

mg/l

2.28

103

128

Adjustment and management of implanted device

2979

22251

1.52

68.13

3.6

3.1

149.34

320.79

mg/l

3.48

2047

14205

Alzheimer’s disease, strict definition

2190

25291

0.65

68.12

2.7

3.2

453.80

378.50

mg/l

0.31

1362

16148

Myalgia

3184

23725

1.46

67.70

3.3

3.2

667.98

401.32

mg/l

1.57

1920

14656

Late syphilis

344

1444

4.25

67.38

6.3

3.3

320.17

264.32

mg/l

0.14

291

962

Mycoses

3866

29845

1.42

67.19

3.9

3.3

614.25

393.98

mg/l

1.70

2652

19075

Degenerative diseases of the nervous system

3604

34370

0.71

67.19

2.8

3.2

516.21

399.50

mg/l

0.69

2253

22042

Fibrosis and cirrhosis of liver

1266

8129

1.95

67.05

3.8

3.2

404.95

284.00

mg/l

0.48

922

5179

Lung cancer and mesothelioma

1842

22569

0.63

66.99

3.1

3.2

506.30

302.33

mg/l

1.02

1232

14229

Gout due to impairment of renal function

261

982

6.32

66.86

7.9

3.2

347.57

240.56

mg/l

0.27

234

659

Polyuria

3514

26933

1.46

66.77

3.5

3.3

460.50

378.26

mg/l

0.44

2289

17522

Late syphilis

297

1178

4.89

66.13

6.6

3.2

354.75

310.49

mg/l

0.09

255

793

Any dementia

4197

37016

0.73

65.93

2.9

3.2

602.66

374.31

mg/l

1.91

2702

23623

Implicit fungal Sepsis

1107

6884

2.02

65.80

4.3

3.2

685.57

298.64

mg/l

1.48

804

4265

Skin changes due to chronic exposure to nonionizing radiation

6253

47472

1.33

65.29

3.5

3.2

434.63

409.02

mg/l

0.16

3932

30001

Actinic keratosis

6090

46331

1.33

64.90

3.6

3.2

443.96

408.28

mg/l

0.22

3841

29309

Psoriasis

4173

32695

1.40

64.76

3.4

3.3

447.51

400.17

mg/l

0.26

2761

20945

Calculus of kidney and ureter

4628

36853

1.38

64.27

3.5

3.3

227.85

393.67

mg/l

2.87

3421

24392

Diseases of the respiratory system

10472

44496

1.23

64.11

3.4

3.2

408.15

310.49

mg/l

1.31

6798

27706

Urolithiasis

5007

40246

1.36

64.01

3.5

3.3

228.37

394.29

mg/l

3.09

3706

26677

Retention of urine

5523

36715

1.34

63.97

3.6

3.3

392.01

370.89

mg/l

0.14

3976

24305

Maternal care for other known or suspected fetal problems

2071

8911

1.56

63.71

3.9

3.3

364.47

485.94

mg/l

0.59

1489

5603

Anxiety (asthma-related co-morbidities)

7877

50646

1.26

63.10

3.3

451.32

425.93

mg/l

0.17

5115

32156

Fracture of lower leg, including ankle

8295

69156

1.26

62.96

3.5

3.3

369.20

417.68

mg/l

0.46

5519

43506

Substance use, excluding alcohol

2595

18975

1.50

62.46

3.4

359.07

394.13

mg/l

0.16

1660

12504

Other disorders of eyelid

7065

56115

1.29

62.33

3.3

3.2

310.26

408.38

mg/l

1.18

4402

34991

Persistent mood disorders

2651

19499

1.50

62.28

3.4

3.2

390.72

407.62

mg/l

0.06

1675

12241

Alzheimer disease

3114

29885

0.70

62.26

2.7

3.2

497.89

393.20

mg/l

0.56

1938

19075

Paracetamol or NSAID medication

2360

8270

1.53

62.18

3.4

280.73

285.38

mg/l

0.02

1613

5472

Chronic ulcer of skin, not elsewhere classified

1116

7053

1.96

62.00

4.6

3.2

642.43

304.94

mg/l

1.41

853

4497

Diseases of external ear

4895

39284

1.35

61.54

3.7

3.3

477.33

397.13

mg/l

0.52

3115

25367

Hyperplasia of prostate

6140

28534

1.32

61.51

3.5

3.3

433.57

332.52

mg/l

0.93

4308

19987

Impingement syndrome of shoulder

3752

29281

1.42

61.37

3.5

3.2

456.55

360.33

mg/l

0.54

2373

18367

Otitis externa

3054

23053

1.46

61.34

3.9

3.3

400.24

417.43

mg/l

0.07

1997

14883

Other disorders of lacrimal gland

5023

40489

1.34

60.84

3.5

3.2

706.67

432.87

mg/l

2.32

3069

24834

Viral pneumonia

1907

13394

1.62

60.75

4.3

3.2

844.92

320.43

mg/l

3.27

1337

8576

Disorders of sclera, cornea, iris and ciliary body

7960

67017

1.26

60.63

3.7

3.3

478.49

414.79

mg/l

0.54

5261

42785

Anxiety disorders, excluding more controls

12259

69049

1.20

60.51

3.3

513.48

411.58

mg/l

1.25

7858

43659

Psoriasis vulgaris

2709

20251

1.49

59.72

3.4

3.3

554.07

409.43

mg/l

0.72

1810

13187

Phobic anxiety disorders

1414

9174

1.68

59.67

3.6

3.4

544.46

364.64

mg/l

0.63

944

6130

Other metabolic disorders

1695

11589

1.64

59.56

3.6

3.0

731.44

395.66

mg/l

1.35

1075

6793

Other necrotizing vasculopathies

1152

7433

1.92

59.35

6.4

3.2

511.72

286.31

mg/l

0.95

866

4696

Other diseases of upper respiratory tract

17569

81177

1.17

59.20

3.3

456.10

394.36

mg/l

0.85

11217

52350

Unspecified nephritic syndrome

415

1974

3.17

58.99

8.1

3.1

297.56

263.42

mg/l

0.10

357

1293

Other abnormal uterine and vaginal bleeding

3082

16617

1.45

58.89

3.3

3.1

391.81

462.79

mg/l

0.33

1729

9605

Other specified and unspecified personality disorders

1168

7410

1.81

58.38

3.4

3.3

438.06

319.55

mg/l

0.36

736

4827

Renal tubulo-interstitial disorders in diseases classified elsewhere

223

814

5.77

58.27

8.4

3.0

592.00

209.65

mg/l

0.61

202

503

Coxarthrosis, primary

9727

70963

1.23

58.21

3.2

3.3

472.39

414.22

mg/l

0.53

6180

44704

Visual disturbances

7017

58694

1.27

58.19

3.4

3.3

658.02

409.96

mg/l

2.84

4411

37178

Alzheimer’s disease (Late onset)

2010

23415

0.66

58.12

2.7

3.2

494.81

381.44

mg/l

0.47

1241

14965

Necrobiosis lipoidica, not elsewhere classified

142

381

8.89

58.10

6.6

3.2

757.00

229.30

mg/l

0.56

113

239

3261

23699

1.44

57.50

3.3

3.1

467.51

395.64

mg/l

0.35

1948

14772

Postmenopausal bleeding

3915

16283

1.40

57.26

3.1

3.0

355.62

497.63

mg/l

0.96

2212

9195

Acute bronchitis

5735

46082

1.30

57.09

3.7

3.2

375.31

411.83

mg/l

0.26

3842

29567

505

9414

0.46

56.83

2.7

3.3

102.79

288.68

mg/l

5.33

355

6425

Other external causes of accidental injury

12958

56472

1.19

56.69

3.4

3.2

473.99

391.39

mg/l

1.02

8335

36344

Other follicular disorders

975

5985

1.91

56.57

4.2

3.3

446.89

336.14

mg/l

0.32

680

3956

Stroke, including SAH

10300

64658

1.22

56.39

3.4

3.3

437.04

401.76

mg/l

0.33

7006

40845

Amputation of foot

478

2467

2.92

56.31

5.7

3.3

345.13

267.88

mg/l

0.24

402

1697

Acute and transient psychotic disorders

1553

10592

1.66

56.23

3.3

352.78

411.90

mg/l

0.19

937

6776

Disorders of lacrimal system

6172

51073

1.29

56.21

3.4

3.2

685.68

435.37

mg/l

2.42

3749

31422

Lesion of ulnar nerve

2007

14432

1.57

56.20

3.4

3.2

491.44

362.39

mg/l

0.56

1367

9356

External causes of morbidity and mortality

10387

44543

1.22

56.13

3.3

3.2

430.91

366.78

mg/l

0.66

6727

28442

Chronic tubulo-interstitial nephritis

612

3342

2.37

56.08

6.0

2.9

114.12

285.59

mg/l

1.62

469

1957

Dermatophytosis

9039

77349

1.23

56.05

3.4

3.3

314.14

407.65

mg/l

1.35

5892

50067

Other acute lower respiratory infections

7486

60023

1.25

55.80

3.7

3.3

488.16

410.20

mg/l

0.71

5104

38836

Other diseases of lip and oral mucosa

5744

47387

1.30

55.64

3.4

3.2

620.95

425.02

mg/l

1.65

3591

29609

Benign neoplasm: Colon, unspecified

3953

31604

1.39

55.02

3.7

3.2

632.95

364.77

mg/l

2.25

2644

20199

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

4628

37328

1.33

55.00

3.5

3.2

584.59

442.15

mg/l

0.95

2980

23055

SLE (Finngen)

508

2604

2.50

54.75

6.2

2.8

805.69

282.88

mg/l

1.12

364

1555

Other anxiety disorders

5603

39611

1.28

54.67

3.3

390.02

412.75

mg/l

0.13

3666

25477

Hyperaldosteronism

499

2625

2.73

54.51

3.8

3.2

76.06

285.50

mg/l

2.21

339

1708

Non-small cell lung cancer, including Hilmo

1297

17954

0.61

54.47

3.1

3.3

501.89

264.41

mg/l

1.02

859

11631

Gingival hyperplasia

560

3019

2.46

54.29

5.9

3.3

295.03

238.48

mg/l

0.21

418

1975

Background retinopathy and retinal vascular changes

377

1779

3.13

54.01

5.8

3.1

282.72

228.20

mg/l

0.13

289

1178

Excessive attrition of teeth

7643

64701

1.24

53.75

3.5

3.3

381.99

413.83

mg/l

0.24

4747

41626

Cervicobrachial syndrome

3091

23791

1.41

53.63

3.1

3.2

591.07

351.03

mg/l

1.51

2002

14781

Exclusions for E4_PCOS_BROAD

2211

16179

1.51

53.52

3.5

3.3

506.06

386.85

mg/l

0.50

1491

10477

Other enthesopathies

4221

33776

1.34

53.42

3.3

3.2

478.68

360.47

mg/l

0.75

2670

20783

Other systemic involvement of connective tissue (FG)

3611

28012

1.38

53.29

3.3

3.1

748.68

362.74

mg/l

3.11

2290

16862

Any dementia, excluding more controls

3979

34115

0.74

53.24

2.9

3.2

602.05

376.97

mg/l

1.79

2561

21662

Ovarian dysfunction

722

4063

1.98

52.86

3.3

3.4

569.35

414.28

mg/l

0.31

482

2630

Wet age-related macular degeneration

2634

19449

1.48

52.55

3.3

3.1

414.44

357.54

mg/l

0.25

1663

12204

Problems related to lifestyle

1362

9150

1.67

52.23

3.6

3.3

387.08

407.05

mg/l

0.06

935

5936

Neoplasms

10759

49204

1.20

51.86

3.5

3.2

589.97

264.03

mg/l

7.77

7202

32196

Nonorganic sleeping disorders, excluding more controls

2308

17002

1.47

51.64

3.2

3.3

534.71

388.50

mg/l

0.63

1471

10973

Cardiomyopathy

2631

20031

1.46

51.57

3.5

3.2

401.91

364.31

mg/l

0.18

1911

12865

Retinal vascular occlusion

1821

13170

1.60

51.46

3.8

3.1

402.04

340.39

mg/l

0.24

1238

8386

Viral warts

1289

8642

1.70

50.96

5.1

3.3

505.11

309.37

mg/l

0.78

950

5557

Sequelae of external causes of morbidity and mortality

3730

29740

1.37

50.75

3.6

3.2

754.48

398.77

mg/l

3.07

2539

18824

Benign neoplasm of other and ill-defined parts of digestive system

2657

20378

1.46

50.71

3.5

3.2

567.44

396.21

mg/l

0.88

1759

12693

Other noninflammatory disorders of uterus, except cervix

3064

15912

1.42

50.70

3.1

582.67

484.40

mg/l

0.38

1747

9055

GI-bleeding

4837

39675

1.31

50.22

3.6

3.2

550.95

371.72

mg/l

1.69

3415

25883

Polycystic ovarian syndrome

510

2602

2.20

50.12

3.2

3.5

506.23

436.89

mg/l

0.11

353

1750

Stroke, excluding SAH

9719

61688

1.22

50.12

3.4

3.3

458.18

396.36

mg/l

0.64

6617

39080

Wegener granulomatosis

304

1372

3.60

50.12

9.7

3.2

379.04

152.01

mg/l

0.52

264

903

Other diseases of the digestive system

4830

39637

1.31

50.06

3.6

3.2

556.64

378.34

mg/l

1.65

3375

25818

Ovarian cyst

4323

19848

1.33

50.03

3.2

654.51

473.14

mg/l

1.04

2571

11723

Other/unspecified cytomegaloviral diseases

341

1601

3.20

49.86

9.1

3.2

1001.33

299.51

mg/l

1.41

301

1036

Other symptoms and signs involving the nervous and musculoskeletal systems

5850

48772

1.27

49.74

3.3

982.58

377.85

mg/l

8.43

4005

30762

Fibroblastic disorders

3534

28048

1.37

49.72

3.5

3.2

340.64

342.89

mg/l

0.01

2275

18006

Bronchitis

16335

91905

1.16

49.71

3.6

3.2

494.63

403.56

mg/l

1.48

11001

58407

Other and unspecified local infections of skin and subcutaneous tissue

1355

9278

1.68

49.65

4.1

3.2

496.08

320.88

mg/l

0.68

969

5975

Retinal vascular disorders

1838

13385

1.58

49.59

3.8

3.1

398.60

345.98

mg/l

0.20

1250

8521

Benign neoplasm: Sigmoid colon

2936

22952

1.44

49.57

3.6

3.3

360.02

396.61

mg/l

0.18

1994

14632

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2257

17018

1.51

49.44

3.7

3.3

397.21

377.02

mg/l

0.08

1598

11273

Accidents

12843

56472

1.18

49.40

3.3

3.2

479.97

391.39

mg/l

1.12

8281

36344

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

15049

85870

1.16

49.14

3.4

3.2

533.54

391.75

mg/l

2.52

9595

55013

Other local infections of skin and subcutaneous tissue

1437

9971

1.65

49.14

4.0

3.2

474.39

308.34

mg/l

0.68

1019

6439

Other CVD

2947

22965

1.42

49.11

3.6

3.2

495.24

350.09

mg/l

0.89

1975

14754

Hidradenitis suppurativa

484

2511

2.36

49.00

3.8

3.4

512.45

305.28

mg/l

0.42

347

1658

Fitting and adjustment of other devices

5713

43101

1.28

48.94

3.3

3.1

265.34

357.46

mg/l

1.12

3957

26737

Osteopathies and chondropathies

8247

66044

1.22

48.93

3.8

3.2

855.28

387.66

mg/l

8.79

5456

41164

Early onset COPD, excluding more controls

3234

25491

1.39

48.74

3.4

3.2

395.25

288.65

mg/l

0.73

2174

16206

Bell's palsy

1638

11645

1.59

48.70

3.5

3.2

503.73

309.92

mg/l

0.81

1112

7420

Sequelae with surgical and medical care as external cause

2982

23314

1.42

48.60

3.6

3.3

822.40

389.39

mg/l

3.26

2020

14770

Microscopic polyangiitis

156

532

8.62

48.36

13.7

3.3

157.67

170.08

mg/l

0.04

147

350

Superficial injury of lower leg

3259

25546

1.37

48.32

3.3

369.44

459.51

mg/l

0.52

2125

16085

Panic disorder

1598

11141

1.55

48.29

3.3

3.4

419.50

383.16

mg/l

0.11

1030

7248

Any prescribed medicine buy

15.93

47.93

3.1

1.7

1167.31

6120.43

mg/l

0.60

Benign neoplasm: Transverse colon

1683

12252

1.62

47.73

3.9

3.3

515.83

342.87

mg/l

0.74

1194

7859

Polyp of the female genital tract

4009

18353

1.34

47.49

3.1

395.81

489.94

mg/l

0.52

2261

10593

Hypotension

2546

19560

1.45

47.48

3.7

3.2

443.88

337.41

mg/l

0.58

1720

12635

Other skin changes

2719

21075

1.43

47.43

4.2

3.2

709.44

364.70

mg/l

2.25

1802

13440

All anxiety disorders

7949

53622

1.22

47.27

3.3

456.40

410.90

mg/l

0.34

5168

34228

Injury, poisoning and certain other consequences of external causes

8385

35846

1.22

47.21

3.3

3.2

381.84

389.39

mg/l

0.05

5411

22527

Mental and behavioural disorders due to alcohol

7530

61939

1.23

47.07

3.3

3.4

337.31

390.20

mg/l

0.53

5085

41547

KRA_PSY_EATING, excluding more controls

679

3833

1.91

46.89

3.8

3.5

349.52

277.74

mg/l

0.16

443

2632

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1518

10651

1.58

46.58

3.5

3.0

781.53

401.48

mg/l

1.40

952

6232

Cholecystitis

2041

15183

1.50

46.43

3.5

3.2

528.77

331.09

mg/l

0.98

1390

9696

Gastroduodenal ulcer

3965

32049

1.33

46.34

3.7

3.2

415.81

350.70

mg/l

0.43

2798

20709

Internal derangement of knee

5323

44031

1.27

46.12

3.3

3.2

359.11

365.35

mg/l

0.03

3367

28024

Other sleep disorders

1500

10582

1.59

45.72

3.6

3.2

515.11

357.91

mg/l

0.57

1029

6800

Trochanteric bursitis

1995

14817

1.50

45.69

3.0

3.1

430.16

337.08

mg/l

0.37

1229

8631

Flat foot [pes planus] (acquired)

1346

9346

1.64

45.67

3.0

3.1

626.92

397.54

mg/l

0.69

755

5514

Myocarditis

550

3007

2.11

45.51

3.5

2.8

642.17

527.39

mg/l

0.17

380

1782

Primary hyperparathyroidism

1614

11699

1.60

45.47

3.6

3.2

693.41

382.00

mg/l

1.20

1055

6985

Type 1 diabetes, strict definition, subgroup 2

19.82

45.45

4.1

2.0

6.55

134.91

mg/l

0.92

Irregular menses

5299

34547

1.26

45.42

3.4

3.2

509.69

485.73

mg/l

0.11

3268

20188

Irritable bowel syndrome

3627

29014

1.33

45.30

3.3

3.2

601.37

398.11

mg/l

1.18

2144

17904

Explicit bacterial Sepsis

1531

10914

1.59

45.23

4.5

3.1

748.67

300.72

mg/l

2.53

1131

6982

Inflammatory diseases of female pelvic organs

7501

47034

1.22

45.22

3.3

3.1

541.19

467.84

mg/l

0.50

4381

27339

Other disorders of penis

1398

9836

1.63

45.09

3.7

3.4

342.05

352.33

mg/l

0.03

961

6930

Intestinal malabsorption

690

4162

2.05

45.07

4.5

3.3

270.27

257.93

mg/l

0.03

484

2675

Impotence

884

5741

1.92

45.01

4.2

3.3

611.58

293.13

mg/l

1.08

669

4049

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

1179

8065

1.72

44.99

4.1

3.2

1934.30

336.48

mg/l

7.60

853

5074

Other diseases of intestine

2193

16649

1.48

44.82

3.8

3.2

411.25

342.76

mg/l

0.31

1580

10622

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2490

31507

0.71

44.70

3.1

3.3

637.46

305.78

mg/l

2.35

1634

20178

Henoch-Schönlein purpura nephritis (HSPN)

100

257

11.50

44.51

8.6

3.1

212.50

80.50

mg/l

2.27

165

Sarcoidosis

1879

13933

1.52

44.39

3.8

3.2

631.56

355.38

mg/l

1.26

1262

8867

Cytomegalovirus infection, IBD co-morbidity

378

1925

2.76

44.29

8.7

3.2

1056.81

258.13

mg/l

1.78

325

1246

Ischaemic Stroke, excluding all haemorrhages

9040

58786

1.21

43.69

3.4

3.3

445.63

397.10

mg/l

0.45

6160

37278

Diaphragmatic hernia

5479

46213

1.27

43.36

3.3

3.2

518.31

396.42

mg/l

0.92

3456

28761

Other viral diseases

4334

35111

1.29

43.12

4.1

3.3

536.50

431.80

mg/l

0.68

3014

23009

Polycystic ovarian syndrome, broad definition

907

5712

1.71

42.86

3.2

3.5

609.50

369.92

mg/l

0.62

618

3769

Cytomegaloviral disease

385

1993

2.67

42.83

8.6

3.2

1044.04

252.76

mg/l

1.79

329

1281

Pre-eclampsia superimposed on chronic hypertension

101

250

6.76

42.63

5.9

2.7

178.13

334.01

mg/l

0.21

154

Keratitis

4884

40644

1.27

42.51

3.7

3.3

433.27

405.12

mg/l

0.15

3226

25952

Cardiodefibrillation

5660

48028

1.27

42.43

3.2

3.3

296.96

406.99

mg/l

1.33

3891

31335

Allergic asthma (mode), excluding more controls

2802

21293

1.36

42.36

3.2

674.45

331.35

mg/l

2.21

1814

13276

Functional dyspepsia

3686

29867

1.32

42.12

3.3

3.2

695.58

402.13

mg/l

1.99

2220

18483

Undetermined asthma, excluding more controls

1797

13237

1.50

42.10

3.4

3.1

494.66

335.16

mg/l

0.64

1094

8017

Cardiac arrest

823

4395

1.81

42.02

3.5

2.7

343.87

459.24

mg/l

0.32

562

2553

Streptococcal septicaemia

1308

9248

1.63

41.54

4.4

3.2

742.23

271.64

mg/l

2.37

956

5918

Disorders of vestibular function (Vertigo)

6936

58765

1.23

41.54

3.2

484.29

432.32

mg/l

0.34

4186

36648

Cardiomyopathies, Primary/intrinsic

1815

13558

1.51

41.08

3.4

3.2

179.87

335.52

mg/l

1.76

1334

8818

Other viral diseases

3372

26885

1.32

40.96

4.4

3.3

623.82

418.16

mg/l

1.39

2385

17660

Iron deficiency anaemia secondary to blood loss (chronic)

2283

17581

1.43

40.96

3.8

3.2

393.67

370.60

mg/l

0.10

1567

11009

Tubulo-interstitial nephritis, not specified as acute or chronic

934

6146

1.75

40.67

4.5

2.9

577.84

257.18

mg/l

1.22

717

3748

Benign paroxysmal vertigo

4200

34768

1.30

40.55

3.2

474.33

450.33

mg/l

0.10

2533

21502

Candidiasis

1787

13274

1.49

40.53

4.0

3.2

627.53

356.04

mg/l

1.27

1194

8324

Alzheimer disease, including avohilmo

3995

34091

0.77

40.47

2.9

3.2

483.73

395.53

mg/l

0.53

2578

21644

Excessive earwax

8279

70623

1.20

40.35

3.4

3.3

440.05

415.72

mg/l

0.17

5317

45307

Benign neoplasm: Adrenal gland

1174

8254

1.69

40.28

3.5

3.2

524.25

295.86

mg/l

0.81

820

5190

Failure and rejection of transplanted organs and tissues

244

1089

3.44

40.23

9.1

3.3

497.92

190.68

mg/l

0.58

218

690

Failed induction of labour

499

2718

2.03

40.22

3.7

3.6

469.45

390.16

mg/l

0.13

363

1779

Other diseases of anus and rectum

4439

36797

1.28

40.18

3.3

3.2

480.84

362.13

mg/l

0.84

2804

23206

Non-small cell lung cancer

770

11722

0.58

40.05

2.9

3.2

543.55

250.61

mg/l

0.97

518

7654

Deforming dorsopathies

3833

31323

1.30

40.04

3.1

3.2

790.79

340.72

mg/l

3.93

2395

19471

1640

11959

1.50

40.01

4.0

3.2

505.68

455.09

mg/l

0.15

1069

7297

Other diseases of arteries and capillaries

1285

9105

1.62

40.00

4.6

3.2

528.26

336.81

mg/l

0.78

946

5752

Blepharochalasis

4450

37188

1.29

39.98

3.2

361.93

422.44

mg/l

0.37

2641

22671

Nonalcoholic steatohepatitis

177

690

4.63

39.96

4.3

3.2

36.90

238.96

mg/l

0.88

130

451

Alcohol-induced acute pancreatitis

580

3494

2.14

39.81

4.0

3.3

397.11

242.49

mg/l

0.39

392

2407

Otitis externa, unspecified

1425

10216

1.56

39.77

4.0

3.3

286.44

333.58

mg/l

0.18

979

6599

Lichen simplex chronicus and prurigo

920

6140

1.78

39.48

3.8

3.2

627.49

252.55

mg/l

1.25

634

3848

Nail disorders

1098

7547

1.66

39.16

4.0

3.3

398.80

357.28

mg/l

0.12

763

4801

Use of pramipexole

3187

25786

1.35

38.96

3.6

3.2

505.52

415.25

mg/l

0.44

2072

15987

Benign neoplasm: Ascending colon

2105

16299

1.46

38.93

3.7

3.3

471.60

351.31

mg/l

0.55

1433

10373

Acute upper respiratory infections of multiple and unspecified sites

10571

69284

1.17

38.72

3.7

3.2

483.95

376.04

mg/l

1.42

7160

44304

Spondylolisthesis/Spondylolysis

2597

20503

1.38

38.25

3.1

3.2

705.80

341.34

mg/l

2.11

1618

12661

Syphilis

414

2276

2.41

38.23

5.6

3.3

410.38

272.55

mg/l

0.35

330

1536

Syphilis

414

2276

2.41

38.23

5.6

3.3

410.38

272.55

mg/l

0.35

330

1536

Other/unspecified synovitis and tenosynovitis

1541

11271

1.52

38.21

3.8

3.2

450.51

374.03

mg/l

0.25

1004

7046

Other symptoms and signs involving cognitive functions and awareness

6958

54866

1.22

38.20

3.2

3.3

585.31

393.50

mg/l

2.07

4476

34980

Triptan medication for migraine, single purchase ok

8040

62513

0.84

38.13

2.9

3.3

636.56

410.77

mg/l

2.62

4826

39180

Migraine, single triptan purchase ok & required. ICD-code if available is included

8040

62513

0.84

38.13

2.9

3.3

636.56

410.77

mg/l

2.62

4826

39180

Ingrowing nail

713

4492

1.86

37.94

4.3

3.3

161.21

332.84

mg/l

1.04

502

2922

Secondary polycythaemia

394

2148

2.49

37.93

3.7

3.3

76.53

233.29

mg/l

1.45

276

1438

Oxycodone

5799

44810

1.24

37.82

3.5

3.2

891.11

346.29

mg/l

8.45

3975

28031

Unspecific neurodegenerative disorder

4904

39596

0.80

37.77

2.9

3.3

470.87

386.26

mg/l

0.58

3167

25186

Pilonidal cyst

1010

6807

1.65

37.67

3.8

3.3

174.05

342.34

mg/l

1.22

703

4662

Zoster [herpes zoster]

7334

62880

1.21

37.61

3.6

3.2

495.13

411.59

mg/l

0.70

4757

39257

Retinal detachments and breaks

5288

45008

1.25

37.57

3.7

3.1

421.86

395.73

mg/l

0.15

3469

28546

Allergic asthma (mode)

2802

21631

1.34

37.56

3.2

674.45

325.68

mg/l

2.28

1814

13552

Emotional disorders starting during childhood or adolecense, excluding more controls

313

1427

2.33

37.45

3.3

3.7

279.33

275.82

mg/l

0.01

218

1106

Cardiomyopathy (excluding other)

1856

14102

1.47

37.40

3.4

3.2

200.52

349.59

mg/l

1.53

1369

9125

Mental and behavioural disorders due to alcohol, excluding acute intoxication

6494

55763

1.22

37.29

3.3

3.4

334.48

388.63

mg/l

0.50

4378

37513

Open wound of ankle and foot

1357

9765

1.55

37.25

4.4

3.3

269.84

337.61

mg/l

0.36

1016

6510

Plantar fascial fibromatosis

1307

9353

1.57

37.25

3.2

361.91

409.64

mg/l

0.13

775

5643

Amenorrhoea

645

3884

1.82

37.13

4.0

3.4

192.38

412.33

mg/l

0.87

422

2474

Dementia

5198

41956

0.80

37.03

3.0

3.3

508.04

373.78

mg/l

1.12

3389

26666

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1570

10057

1.45

37.02

3.5

3.7

418.01

415.15

mg/l

0.01

1119

7170

Granulomatous disorders of skin and subcutaneous tissue

391

2114

2.38

37.02

4.9

3.2

705.84

283.16

mg/l

0.73

261

1300

Urticaria and erythema

4524

37780

1.26

36.93

3.6

3.3

445.23

437.40

mg/l

0.04

2836

23809

Other problems related to primary support group, including family circumstances

1122

7489

1.58

36.86

3.9

3.4

237.89

421.31

mg/l

1.01

793

4878

Leiomyoma of uterus

8051

39718

1.20

36.73

3.1

501.05

482.89

mg/l

0.10

4492

22799

Corns and callosities

973

6671

1.71

36.72

4.8

3.2

542.74

324.87

mg/l

0.73

724

4191

Alcohol use disorder, ICD-based

5977

51319

1.23

36.69

3.3

3.4

324.10

382.99

mg/l

0.55

4020

34488

Second line medication for Crohn's disease

8071

70738

1.19

36.46

4.0

3.2

1033.02

369.12

mg/l

14.22

5526

44496

L04AX Other immunosuppressants

7879

68964

1.19

36.40

4.0

3.2

1058.66

365.56

mg/l

14.72

5385

43339

Gastric ulcer

2630

20949

1.37

36.36

3.7

3.2

431.52

329.85

mg/l

0.56

1813

13387

Hydronephrosis

1585

11785

1.50

36.33

4.2

2.9

265.38

281.80

mg/l

0.07

1207

7266

Undetermined asthma

1797

13557

1.45

36.17

3.4

3.1

494.66

335.37

mg/l

0.64

1094

8286

Preterm labour and delivery

2864

22869

1.33

36.01

3.6

3.2

372.28

519.93

mg/l

0.93

1791

12994

Chronic sinusitis

5935

50871

1.22

35.97

3.4

3.3

607.20

397.05

mg/l

1.95

3713

32241

Cervicalgia

2836

22723

1.34

35.97

3.1

3.2

504.68

360.56

mg/l

0.73

1765

14173

Conjunctivitis (acute, non atopic)

3497

28476

1.30

35.90

3.7

3.3

480.62

448.56

mg/l

0.14

2323

18283

Diseases of inner ear

8088

68798

1.19

35.87

3.2

3.3

481.62

428.86

mg/l

0.38

4910

43273

Acute upper respiratory infections

15756

88121

1.13

35.52

3.6

3.2

558.58

389.04

mg/l

3.47

10337

56044

Acute peritonitis

903

6129

1.72

35.51

7.4

3.3

529.60

276.16

mg/l

1.31

749

4014

Non-allergic asthma (mode), excluding more controls

2628

20658

1.35

35.48

3.2

3.1

581.26

319.85

mg/l

1.62

1712

12591

Monoamine oxidase A inhibitors

1633

12242

1.48

35.36

3.3

251.87

407.78

mg/l

0.87

1022

7631

Glucosamine medication

7514

52617

1.21

35.25

3.1

3.2

417.85

410.85

mg/l

0.04

4359

32479

Anxiety disorders

12746

79858

1.15

35.10

3.4

3.3

513.47

411.17

mg/l

1.31

8203

50596

Other benign neoplasms of skin

5302

45324

1.24

34.95

3.6

3.2

454.39

412.63

mg/l

0.24

3367

28463

Abnormalities of gait and mobility

1751

13376

1.47

34.89

3.6

3.3

802.30

315.17

mg/l

2.61

1224

8633

Neurotic, stress-related and somatoform disorders

12579

79097

1.15

34.88

3.4

3.3

513.94

410.57

mg/l

1.32

8096

50085

Generalized anxiety disorder

1580

11617

1.45

34.83

3.1

3.4

425.00

370.01

mg/l

0.17

997

7603

Cardiac murmurs and other cardiac sounds

1081

7399

1.58

34.79

4.0

3.2

592.14

356.48

mg/l

0.73

704

4676

N06DA Anticholinesterases

3747

35437

0.78

34.60

2.8

3.2

396.28

401.68

mg/l

0.02

2375

22563

Use of anticholinesterases

3747

35437

0.78

34.60

2.8

3.2

396.28

401.68

mg/l

0.02

2375

22563

Neovascular glaucoma

580

3577

1.96

34.55

4.9

3.1

477.58

281.59

mg/l

0.54

429

2298

Nondiabetic hypoglycaemic coma

247

7.74

34.47

6.8

3.2

671.60

86.04

mg/l

0.47

173

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

235

1070

2.89

34.36

5.0

3.3

774.03

114.35

mg/l

1.05

179

716

Diseases of salivary glands

4299

36099

1.26

34.34

3.4

3.3

701.85

420.53

mg/l

2.22

2711

22600

Dementia in Alzheimer disease

1555

17464

0.70

34.29

2.7

3.2

447.39

349.50

mg/l

0.35

940

11221

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

1861

14330

1.45

34.25

3.8

3.2

262.60

281.24

mg/l

0.08

1294

9280

Diseases of peritoneum

1396

10293

1.53

34.18

5.9

3.2

528.34

324.65

mg/l

1.01

1047

6556

Dermatophytosis

1839

14145

1.45

34.16

3.8

3.3

560.34

383.14

mg/l

0.75

1301

9253

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2784

21908

1.32

34.16

3.6

3.3

394.98

428.90

mg/l

0.15

1900

14335

Benign neoplasm of other and unspecified endocrine glands

1832

14081

1.45

34.16

3.5

3.3

560.59

363.80

mg/l

0.83

1258

8866

SLE, strict definition

490

2908

2.09

34.11

6.3

3.2

824.58

387.16

mg/l

0.82

354

1784

SLE, ICD10

490

2908

2.09

34.11

6.3

3.2

824.58

387.16

mg/l

0.82

354

1784

Radial styloid tenosynovitis [de Quervain]

704

4511

1.78

34.01

4.0

3.1

208.82

371.73

mg/l

0.64

464

2726

Social phobias

817

5330

1.66

33.95

3.6

3.5

637.67

310.41

mg/l

0.85

531

3657

Enthesopathies of lower limb, excluding foot

2975

24102

1.32

33.92

3.2

3.3

449.29

340.14

mg/l

0.57

1818

15104

Propionic acid derivatives

4062

16795

1.27

33.89

3.3

3.7

299.74

411.80

mg/l

0.96

2722

11463

Systemic lupus erythematosus

508

3048

2.05

33.85

6.2

3.2

805.69

406.20

mg/l

0.75

364

1890

Coagulation defects, purpura and other haemorrhagic conditions

2523

20101

1.35

33.82

4.0

3.3

730.60

357.19

mg/l

2.56

1801

12974

Primary coxarthrosis, bilateral

4322

36584

1.27

33.82

3.2

577.57

407.18

mg/l

1.19

2728

22891

Endometriosis

4052

19630

1.27

33.56

3.1

3.2

563.56

478.87

mg/l

0.38

2336

11552

Agoraphobia

343

1774

2.23

33.51

3.4

470.54

285.09

mg/l

0.27

222

1199

Acute nephritic syndrome

340

1835

2.48

33.44

8.7

3.1

220.73

170.15

mg/l

0.31

300

1214

Membranous nephropathy

104

342

7.98

33.43

11.9

3.1

331.52

233.96

mg/l

0.22

222

Disturbances of skin sensation

3431

28210

1.29

33.33

3.2

3.3

717.00

435.00

mg/l

1.76

2155

17875

Intracranial injury

8318

69435

1.18

33.24

3.2

3.3

420.20

415.44

mg/l

0.03

5419

45087

Hyperkinetic disorders, excluding more controls

791

4863

1.64

33.24

3.3

3.7

436.32

398.94

mg/l

0.08

551

3551

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1359

10039

1.53

33.24

3.6

3.3

713.93

323.16

mg/l

1.65

921

6495

All influenza (not pneumonia)

1955

15093

1.40

33.23

4.0

3.2

585.40

308.65

mg/l

1.47

1364

9787

Smoking dependency

1198

8667

1.57

33.17

3.8

3.3

151.35

332.68

mg/l

1.86

772

5575

Mental and behavioural disorders due to tobacco

1198

8670

1.57

33.11

3.8

3.3

151.35

309.79

mg/l

1.54

772

5594

Diabetic nephropathy, excluding more controls

4287

31255

1.42

33.07

7.3

3.5

364.67

113.07

mg/l

11.39

3843

21071

Abnormal results of function studies

1173

8461

1.56

32.50

3.8

3.3

628.79

337.56

mg/l

1.01

775

5417

Dysphagia

3632

30277

1.28

32.27

3.4

3.2

809.77

351.97

mg/l

4.06

2390

18961

Chronic rhinitis, nasopharyngitis and pharyngitis

4217

35497

1.25

32.16

3.5

3.3

474.28

402.98

mg/l

0.40

2600

22446

Pruritus

1399

10364

1.49

32.11

3.9

3.2

904.46

331.21

mg/l

2.42

895

6428

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

789

5405

1.80

32.07

5.1

3.2

5928.11

181.21

mg/l

20.48

601

3431

Traction detachment of retina

158

642

3.94

31.89

7.6

3.1

215.04

156.40

mg/l

0.24

131

417

Erosion of teeth , including avohilmo

2854

23089

1.31

31.88

3.9

3.4

470.69

433.89

mg/l

0.14

1774

15085

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

4228

35298

1.24

31.87

3.3

356.49

440.13

mg/l

0.59

2762

22876

Viral warts

2532

20244

1.33

31.77

4.2

3.3

367.80

428.17

mg/l

0.29

1763

13093

Benign neoplasm: Rectum, anus and anal canal

2977

24497

1.32

31.74

3.4

3.3

507.51

390.10

mg/l

0.60

1983

15659

Unspecified urinary incontinence

1221

8931

1.55

31.67

3.5

3.1

322.95

340.17

mg/l

0.04

645

5336

Other viral diseases, not elsewhere classified

2135

16679

1.36

31.52

4.0

3.3

683.18

403.48

mg/l

1.41

1487

10901

Benign neoplasm: Rectum

2677

21837

1.35

31.48

3.4

3.3

442.05

380.35

mg/l

0.27

1791

13986

Symptoms and signs concerning food and fluid intake

1462

10948

1.48

31.44

3.6

3.2

807.59

243.52

mg/l

2.76

962

6879

Other and unspecified mood [affective] disorders

730

4745

1.69

31.38

3.3

3.4

335.55

282.61

mg/l

0.12

477

3162

Post-traumatic stress disorder

753

4905

1.66

31.30

3.1

3.4

1006.12

337.71

mg/l

1.66

496

3300

Thyrotoxicosis, other and/or unspecified

2480

19863

1.33

31.12

3.5

3.1

496.30

398.30

mg/l

0.42

1600

12066

Other viral diseases, not elsewhere classified

2949

23831

1.29

31.10

3.8

3.3

564.73

422.84

mg/l

0.75

2019

15558

Other and unspecified vascular occlusions

1347

10074

1.52

30.99

3.6

3.1

442.68

320.85

mg/l

0.42

900

6403

Fungal Sepsis

618

4014

1.88

30.95

4.8

3.2

878.08

258.81

mg/l

1.75

464

2539

Other shoulder lesions

1196

8678

1.52

30.92

3.7

3.2

466.04

365.89

mg/l

0.28

799

5456

Misadventures to patients during surgical and medical care

1943

15213

1.40

30.89

3.7

3.2

485.88

371.44

mg/l

0.49

1351

9637

Thyrotoxicosis

3252

26883

1.29

30.70

3.6

3.2

503.94

427.44

mg/l

0.36

2092

16242

Other enthesopathy of foot (+metatarsalgia)

1303

9608

1.49

30.68

3.3

3.2

330.33

368.01

mg/l

0.11

797

5822

Vascular disorders of the intestines

1015

7257

1.61

30.62

3.8

3.2

655.24

250.05

mg/l

1.61

746

4654

Renal agenesis and other reduction defects of kidney

109

371

5.21

30.54

7.5

3.2

171.94

255.54

mg/l

0.20

234

Complications of internal orthopaedic prosthetic devices, implants and grafts

3319

27662

1.29

30.54

3.2

704.74

391.22

mg/l

2.27

2175

17110

Nonorganic sleeping disorders

2308

18318

1.34

30.53

3.2

3.3

534.71

407.72

mg/l

0.52

1471

11897

Other disorders of nervous system

974

6950

1.63

30.21

4.0

3.3

668.98

283.99

mg/l

1.28

656

4397

Female infertility, associated with anovulation

635

3998

1.70

30.05

3.2

3.5

667.99

436.17

mg/l

0.43

436

2601

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1554

11958

1.47

29.96

3.8

3.2

481.08

277.13

mg/l

1.08

1077

7828

Acute suppurative otitis media

2489

18497

1.31

29.91

4.0

3.5

364.48

398.67

mg/l

0.15

1723

12505

Donors of organs and tissues

222

1054

2.80

29.85

2.9

3.2

337.62

180.78

mg/l

0.21

121

692

Implicit fungal Sepsis

572

3686

1.91

29.77

4.9

3.2

942.72

261.03

mg/l

1.81

430

2339

Any event in hilmo or specialist outpatient

133

4.58

29.73

3.2

2.4

136.27

11.24

mg/l

1.95

Allergic purpura

403

2333

2.09

29.73

4.9

3.4

529.27

302.02

mg/l

0.44

311

1521

Benign neoplasm: Stomach

1383

10465

1.50

29.70

3.6

3.2

506.96

337.72

mg/l

0.59

873

6468

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

7476

64218

1.18

29.67

3.4

3.3

464.69

393.23

mg/l

0.58

4759

41625

Prolonged pregnancy

554

7766

0.60

29.66

2.0

3.4

864.41

519.00

mg/l

0.54

326

4877

In situ neoplasms

5286

45757

1.22

29.60

3.6

3.2

412.13

424.59

mg/l

0.07

3424

28440

Abnormal findings on diagnostic imaging of other body structures

1898

14938

1.40

29.43

3.4

3.2

980.23

403.05

mg/l

2.95

1226

9248

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2306

11463

1.32

29.25

3.9

3.3

505.47

490.83

mg/l

0.05

1686

7335

Diabetic nephropathy

4321

38151

1.38

29.06

7.3

3.8

364.21

137.04

mg/l

9.63

3873

26636

Non-allergic asthma (mode)

2628

21148

1.31

29.02

3.2

3.1

581.26

328.50

mg/l

1.53

1712

13049

Subjective visual disturbances

3321

27685

1.28

29.02

3.3

521.35

422.68

mg/l

0.47

2068

17279

Oesophageal varices

634

4219

1.84

28.95

3.9

3.3

343.81

272.52

mg/l

0.18

428

2790

Calcific tendinitis of shoulder

772

5267

1.68

28.92

3.3

3.1

375.12

383.20

mg/l

0.02

496

3226

Somatoform disorder

2000

15757

1.36

28.89

3.3

3.2

846.20

385.18

mg/l

2.12

1223

9848

Systemic lupus erythematosus, unspecified

418

2489

2.07

28.81

5.6

3.1

965.65

370.63

mg/l

1.00

295

1514

Macular pucker

2301

18703

1.37

28.75

3.6

3.2

403.00

378.43

mg/l

0.09

1450

11797

Hirsutism in women

215

997

2.61

28.73

3.6

3.4

356.23

207.67

mg/l

0.19

136

651

Other hearing loss

3985

33095

1.25

28.70

3.4

3.2

468.04

404.99

mg/l

0.33

2424

21302

Other extrapyramidal and movement disorders in other diseases

3286

27477

1.28

28.67

3.3

3.2

657.02

397.83

mg/l

1.64

2057

17270

Other systemic involvement of connective tissue

3675

30978

1.26

28.49

3.3

3.2

735.92

407.21

mg/l

2.45

2337

18853

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1164

8558

1.51

28.47

3.7

3.2

794.03

322.27

mg/l

1.69

778

5407

Congenital malformations, deformations and chromosomal abnormalities

7287

61231

1.17

28.37

4.0

3.3

475.94

411.10

mg/l

0.54

5043

39252

Hypertrichosis

243

1191

2.44

28.23

3.6

3.3

310.68

182.40

mg/l

0.19

158

768

Metatarsalgia

1210

8944

1.49

28.22

3.3

3.2

357.44

370.76

mg/l

0.03

733

5402

Unspecified dementia

802

10383

0.64

28.16

2.9

3.2

667.69

331.22

mg/l

0.86

508

6719

Alcohol abuse, main dg, excluding more controls

1888

14830

1.37

28.03

3.4

3.3

216.24

356.98

mg/l

1.17

1267

10030

Early onset COPD

3234

27117

1.28

27.95

3.4

3.3

395.25

383.24

mg/l

0.05

2174

17644

Lateral epicondylitis

1697

13175

1.40

27.89

3.3

3.2

661.49

393.37

mg/l

1.00

1096

8216

Glaucoma secondary to other eye disorders

581

3784

1.83

27.86

4.9

3.2

476.49

331.02

mg/l

0.37

430

2472

Benign neoplasm: Descending colon

1043

7677

1.59

27.80

3.8

3.3

296.01

289.21

mg/l

0.02

744

4941

Persons encountering health services in circumstances related to reproduction

5853

45222

0.84

27.75

3.3

604.18

394.46

mg/l

2.00

3726

28669

Migraine without aura

1831

14199

1.35

27.57

3.3

533.79

443.93

mg/l

0.29

1141

8881

Other diseases of stomach and duodenum

925

6632

1.60

27.50

4.1

3.2

559.48

292.47

mg/l

0.84

644

4192

Hypercalcemia

638

4297

1.80

27.46

4.4

3.2

1512.00

276.76

mg/l

3.43

477

2685

Injuries to the thorax

6516

57455

1.18

27.46

3.5

3.3

515.56

400.43

mg/l

1.06

4403

37425

Presbycusis

1929

15154

1.37

27.41

3.3

3.2

592.35

391.22

mg/l

0.81

1137

9779

Neuromuscular dysfunction of bladder

1253

9412

1.49

27.40

3.5

3.2

805.35

276.73

mg/l

2.11

815

6007

Disorders of ocular muscles, binocular movement, accommodation and refraction

5821

50361

1.19

27.34

3.4

3.3

610.10

408.18

mg/l

1.84

3738

32216

Persons encountering health services for specific procedures, not carried out

1037

7503

1.53

27.32

3.6

3.1

137.65

251.02

mg/l

1.02

720

4777

Fracture of foot, except ankle

2953

24401

1.28

27.31

3.8

3.3

638.64

442.90

mg/l

1.07

1929

15689

Emotional disorders and disorders of social functioning with onset specific to childhood

339

1804

1.99

27.19

3.3

3.8

482.87

282.82

mg/l

0.30

233

1383

Infective dermatitis

1527

11788

1.42

27.11

3.6

3.2

580.53

308.00

mg/l

1.21

1030

7611

Psychotic depression

754

5143

1.63

27.10

3.3

657.14

284.13

mg/l

0.94

493

3282

Hypopituitarism

842

5884

1.60

27.10

3.3

589.46

263.47

mg/l

1.00

580

3978

Urticaria

3499

29371

1.25

26.99

3.6

3.3

451.71

436.90

mg/l

0.06

2193

18526

Other and unspecified effects of external causes

3184

26492

1.26

26.96

3.5

3.3

313.06

440.32

mg/l

0.97

2119

17151

Iridocyclitis

2969

24663

1.28

26.96

3.7

3.3

558.06

418.44

mg/l

0.75

1968

15750

Type 1 diabetes, wide definition, subgroup 2

154

623

2.89

26.96

5.0

2.0

369.08

397.85

mg/l

0.03

119

350

Triptan medication for migraine, min. 3 purchases

4951

43810

0.84

26.91

2.8

3.3

652.10

431.81

mg/l

1.66

2921

27217

Oligomenorrhoea

391

2272

1.97

26.91

3.7

3.3

625.15

345.89

mg/l

0.45

248

1389

L02BA Anti-estrogens

1286

16946

0.71

26.90

2.8

3.1

652.32

474.32

mg/l

0.45

684

9629

Purpura and other haemorrhagic conditions

1748

13734

1.39

26.88

4.1

3.3

759.45

326.00

mg/l

2.43

1261

8866

Other obstetric conditions, not elsewhere classified

2366

11946

1.30

26.87

3.8

3.3

495.17

495.37

mg/l

0.00

1721

7617

Supervision of normal pregnancy

1158

9065

0.70

26.80

2.4

3.2

843.32

454.62

mg/l

1.11

713

5420

Renal agenesis and other reduction defects of kidney

322

5.18

26.78

8.3

3.2

182.56

278.93

mg/l

0.20

208

Other symptoms and signs involving the circulatory and respiratory systems

864

6102

1.59

26.55

3.2

1064.20

284.95

mg/l

2.36

577

3915

Short Achilles tendon (acquired)

387

2298

2.04

26.47

2.9

3.1

2917.24

386.22

mg/l

3.02

205

1379

Injuries to the ankle and foot

9240

73806

1.14

26.45

3.6

3.3

413.16

406.79

mg/l

0.05

6168

47509

Drug-induced cataract

356

2097

2.18

26.43

6.2

3.2

589.96

208.79

mg/l

0.78

271

1312

Fissure and fistula of anal and rectal regions

3317

27878

1.26

26.41

3.4

3.2

530.19

348.08

mg/l

1.11

2044

17845

Other and unspecified drugs and medicaments

1097

8103

1.51

26.40

3.8

3.3

825.43

339.05

mg/l

1.65

742

5142

Other symptoms and signs involving the digestive system and abdomen

2233

18043

1.33

26.39

3.3

3.1

216.67

346.54

mg/l

1.01

1313

10640

Chronic laryngitis and laryngotracheitis

1895

15085

1.37

26.33

3.5

3.2

439.65

389.87

mg/l

0.16

1098

9568

Disorders of psychological development

965

6314

1.50

26.33

3.4

3.6

541.79

350.93

mg/l

0.53

689

4451

Zoster [herpes zoster]

2502

20555

1.31

26.21

4.0

3.2

764.89

377.52

mg/l

2.41

1700

12837

Rheumatoid arthritis

4412

34008

1.22

26.15

3.2

3.1

755.42

380.38

mg/l

3.63

2937

20911

Mental disorders, not otherwise specified

879

6198

1.55

25.97

3.1

3.4

806.46

348.57

mg/l

1.22

558

4029

Convulsions, not elsewhere classified

2975

24375

1.27

25.97

3.7

3.3

315.27

305.14

mg/l

0.05

2033

15867

Other diseases of blood and blood-forming organs

958

6984

1.57

25.93

3.6

3.3

781.96

294.60

mg/l

1.60

629

4480

Other and unspecified tonsillitis

3674

25985

1.23

25.92

3.5

3.4

429.57

338.70

mg/l

0.59

2559

17721

Amputation of ankle bones

338

1970

2.20

25.92

6.4

3.2

261.74

280.85

mg/l

0.09

285

1332

Primary open-angle glaucoma

4664

39154

1.22

25.88

3.4

3.2

383.72

392.18

mg/l

0.04

2892

24633

Malignant neoplasm of urinary organs

1445

11237

1.44

25.75

3.7

3.2

517.57

266.61

mg/l

1.33

996

7353

Coeliac disease

1491

11510

1.41

25.72

4.2

3.3

578.90

339.11

mg/l

0.89

954

7259

COPD (mode)

4978

34080

1.21

25.67

3.3

3.2

318.54

299.44

mg/l

0.13

3416

21259

Use of donepezil

1909

22723

0.75

25.61

2.7

3.2

588.14

384.18

mg/l

0.87

1179

14494

Dementia, including avohilmo

5709

44513

0.84

25.57

3.1

3.3

482.93

390.36

mg/l

0.72

3751

28278

Adverse effects, not elsewhere classified

2267

18353

1.31

25.54

3.6

3.3

338.52

410.34

mg/l

0.33

1466

11627

Other eating disorders

413

2436

1.84

25.50

3.8

3.6

212.52

332.66

mg/l

0.30

275

1727

Amyloidosis

335

1955

2.19

25.50

5.2

3.0

2307.12

321.96

mg/l

3.67

255

1227

Use of disulfiram, acamprosate or naltrexone

1130

8428

1.49

25.49

3.1

3.3

165.09

409.68

mg/l

1.88

697

5719

Cyst of kidney

1038

7731

1.55

25.43

3.9

3.2

865.17

298.56

mg/l

2.14

746

4970

Pain associated with micturition

1494

11579

1.41

25.43

3.6

3.2

535.52

332.60

mg/l

0.75

933

7242

Meralgia paraesthetica

483

3090

1.89

25.35

3.2

3.1

334.50

305.33

mg/l

0.05

292

1957

Chronic hepatitis, not elsewhere classified

476

3031

1.89

25.34

4.0

3.2

164.87

288.68

mg/l

0.50

326

1883

Undefined dementia

806

10499

0.66

25.27

2.9

3.1

663.93

328.20

mg/l

0.87

511

6779

Corneal ulcer

2301

18731

1.31

25.23

3.8

3.3

270.76

396.88

mg/l

0.89

1544

12132

Brachial plexus disorders

1032

7534

1.49

25.18

3.0

3.1

678.72

428.74

mg/l

0.61

659

4704

Amyloidosis, other/unspecified

288

1624

2.36

25.14

5.7

3.0

2612.49

351.23

mg/l

3.65

223

1010

Stomatitis and related lesions

2384

19486

1.30

25.11

3.5

3.3

941.54

371.14

mg/l

3.64

1521

12413

Other and unspecified vasculitis limited to skin

362

2171

2.11

25.11

4.1

3.1

436.86

294.88

mg/l

0.23

258

1350

Speech and linguistic disorders, excluding more controls

682

4277

1.60

25.11

3.6

3.5

610.95

275.41

mg/l

0.85

503

3007

Left bundle-branch block

1036

7675

1.52

25.08

3.5

3.1

389.30

314.58

mg/l

0.20

645

4725

Pain in thoracic spine

1909

15220

1.34

25.04

3.1

3.3

778.54

328.10

mg/l

2.24

1199

9546

Disorder of pancreatic internal secretion, other and/or unspecified

137

591

3.76

25.00

5.2

3.2

39.68

171.53

mg/l

0.65

105

381

Eating disorder

679

4522

1.59

24.99

3.8

3.5

349.52

351.40

mg/l

0.00

443

3133

Other noninfective gastroenteritis and colitis

3076

25747

1.26

24.92

3.7

3.2

457.03

405.43

mg/l

0.24

2057

16290

Radiculopathy

2220

18082

1.32

24.86

3.3

3.2

708.92

352.58

mg/l

1.93

1458

11396

Follicular cysts of skin and subcutaneous tissue

2384

19565

1.30

24.74

3.6

3.3

587.71

410.33

mg/l

0.83

1626

12650

Primary open-angle glaucoma, strict

3810

32656

1.24

24.71

3.4

3.2

412.77

401.94

mg/l

0.05

2356

20409

Pustular psoriasis

631

4297

1.71

24.60

3.4

3.2

473.81

362.91

mg/l

0.21

390

2632

Myocardial infarction, with ST-elevation

2523

20910

1.30

24.56

3.4

3.3

378.26

361.83

mg/l

0.07

1751

13980

Anti-inflammatory and antirheumatic products, non-steroids

3949

16798

1.23

24.40

3.3

3.7

286.61

411.69

mg/l

1.20

2640

11466

Malignant neoplasm of kidney, except renal pelvis

1326

10279

1.45

24.36

3.8

3.2

557.78

254.58

mg/l

1.56

907

6708

Pustulosis palmaris et plantaris

576

3858

1.75

24.35

3.5

3.2

508.50

362.13

mg/l

0.27

358

2370

Vasculitis limited to skin, not elsewhere classified

392

2419

2.02

24.33

4.1

3.1

413.32

267.77

mg/l

0.26

276

1509

Lichen sclerosus et atrophicus

1342

10348

1.43

24.32

3.3

3.1

332.74

424.19

mg/l

0.33

833

5973

Disorders of muscles

1281

9763

1.43

24.27

3.3

3.2

470.79

377.21

mg/l

0.27

841

6225

Later onset COPD

3247

30339

0.80

23.88

3.2

3.3

273.91

370.18

mg/l

0.96

2280

19775

Other complications of surgical and medical care, not elsewhere classified

1236

9412

1.44

23.87

3.5

3.2

671.25

324.05

mg/l

1.23

815

5879

Excessive vomiting in pregnancy

717

4914

1.57

23.86

3.5

3.1

798.78

514.90

mg/l

0.53

463

2839

Other bacterial intestinal infections

3008

25298

1.26

23.75

4.1

3.2

991.96

376.70

mg/l

5.32

2035

15939

Visual impairment including blindness (binocular or monocular)

888

6449

1.54

23.70

4.5

3.2

379.77

322.74

mg/l

0.15

582

4144

Hypertrophy of breast in women and men

2262

18470

1.30

23.69

3.0

3.2

380.11

465.33

mg/l

0.36

1304

11083

Congenital malformations, deformations and chromosomal abnormalities

8114

67137

1.14

23.56

3.9

3.3

455.17

410.05

mg/l

0.36

5523

42938

Schizotypal disorder

292

1641

2.13

23.52

3.0

3.4

479.03

305.68

mg/l

0.22

174

1079

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Albumin [Mass/volume] in Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS